TY - JOUR A1 - Steinhardt, Maximilian J. A1 - Krummenast, Franziska C. A1 - Rosenwald, Andreas A1 - Gerhard-Hartmann, Elena A1 - Heidemeier, Anke A1 - Einsele, Hermann A1 - Topp, Max S. A1 - Duell, Johannes T1 - R-CHOP intensification with mid-cycle methotrexate and consolidating AraC/TT with BCNU/aHSCT in primary aggressive lymphoma with CNS involvement JF - Journal of Cancer Research and Clinical Oncology N2 - Purpose Patients suffering from aggressive systemic peripheral lymphoma with primary central nervous system involvement (PCL) are a rare and sparsely investigated population. Recommended treatment regimens include a combination of intrathecal and systemic chemotherapy as well as whole brain radiotherapy while offering relatively poor survival. Methods We conducted a single-center retrospective study that analyzed safety and outcome of 4 + 4 cycles Rituximab (R)-CHOP and R-high-dose Methotrexate (HD-MTX) for newly diagnosed, transplant-eligible patients ("Ping-Pong"), followed by Cytarabine (AraC)/Thiotepa (TT), BCNU/TT, and autologous hematologic stem cell transplantation (aHSCT). We retrospectively analyzed a set of 16 patients with high-intermediate or high-risk IPI status. Results Overall response rate to Ping-Pong was 100% measured by CT/MRI, including 93.75% complete remissions after BCNU/TT followed by PBSCT. One patient failed to qualify for high-dose chemotherapy due to progression when receiving Cytarabine/TT. All patients experienced grade III adverse events, 3 of them a grade IV adverse event. Estimated progression-free survival is 93.75% after a 4.8-year follow-up currently. Conclusion Our study suggests high effectivity of R-CHOP with mid-cycle MTX with aHSCT consolidation towards acceptable OS results in this challenging patient population. KW - lymphoma KW - HD KW - MTX KW - R-CHOP Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-267731 SN - 1432-1335 VL - 148 IS - 1 ER - TY - JOUR A1 - Gernert, Michael A1 - Schmalzing, Marc A1 - Tony, Hans-Peter A1 - Strunz, Patrick-Pascal A1 - Schwaneck, Eva Christina A1 - Fröhlich, Matthias T1 - Calprotectin (S100A8/S100A9) detects inflammatory activity in rheumatoid arthritis patients receiving tocilizumab therapy JF - Arthritis Research & Therapy N2 - Background Assessing serological inflammation is difficult in tocilizumab (TCZ)-treated rheumatoid arthritis (RA) patients, as standard inflammation parameters, like erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), are influenced by interleukin-6-receptor inhibition. Calprotectin in the serum, also named S100A8/S100A9, might be a more useful inflammation parameter in TCZ-treated patients. Methods Sixty-nine RA patients taking TCZ were included. Serum-calprotectin levels were assessed, as well as ESR, CRP, need for a change in disease-modifying anti-rheumatic drugs due to RA activity (= active RA), and the RA clinical disease activity score (CDAI). Forty-five RA patients taking tumor-necrosis factor-inhibitors (TNFi) were investigated for the same parameters. Results TCZ-treated patients with active RA had higher calprotectin values than not active RA patients (4155.5 [inter quartile range 1865.3–6068.3] vs 1040.0 [676.0–1638.0] ng/ml, P < 0.001). A calprotectin cut-off value of 1916.5 ng/ml resulted in a sensitivity and specificity of 80.0 %, respectively, for the detection of RA disease activity. Calprotectin values correlated with CDAI-scores (r = 0.228; P = 0.011). ESR and CRP were less suitable to detect RA activity in TCZ-treated patients. Also TNFi-treated patients with active RA had higher calprotectin values compared to not active RA (5422.0 [3749.0–8150.8] vs 1845.0 [832.0–2569.0] ng/ml, P < 0.001). The calprotectin value with the best sensitivity and specificity for detecting RA activity was 3690.5 ng/ml among TNFi-treated patients. Conclusion Calprotectin in the serum can be a useful inflammation parameter despite TCZ-treatment. KW - calprotectin KW - inflammation marker KW - c-reactive protein KW - tocilizumab KW - rheumatoid arthritis KW - S100A8/S100A9 Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-300523 VL - 24 IS - 1 ER - TY - JOUR A1 - Hoffmann, Jan V. A1 - Janssen, Jan P. A1 - Kanno, Takayuki A1 - Shibutani, Takayuki A1 - Onoguchi, Masahisa A1 - Lapa, Constantin A1 - Grunz, Jan-Peter A1 - Buck, Andreas K. A1 - Higuchi, Takahiro T1 - Performance evaluation of fifth-generation ultra-high-resolution SPECT system with two stationary detectors and multi-pinhole imaging JF - EJNMMI Physics N2 - Background Small-animal single-photon emission computed tomography (SPECT) systems with multi-pinhole collimation and large stationary detectors have advantages compared to systems with moving small detectors. These systems benefit from less labour-intensive maintenance and quality control as fewer prone parts are moving, higher accuracy for focused scans and maintaining high resolution with increased sensitivity due to focused pinholes on the field of view. This study aims to investigate the performance of a novel ultra-high-resolution scanner with two-detector configuration (U-SPECT5-E) and to compare its image quality to a conventional micro-SPECT system with three stationary detectors (U-SPECT\(^+\)). Methods The new U-SPECT5-E with two stationary detectors was used for acquiring data with \(^{99m}\)Tc-filled point source, hot-rod and uniformity phantoms to analyse sensitivity, spatial resolution, uniformity and contrast-to-noise ratio (CNR). Three dedicated multi-pinhole mouse collimators with 75 pinholes each and 0.25-, 0.60- and 1.00-mm pinholes for extra ultra-high resolution (XUHR-M), general-purpose (GP-M) and ultra-high sensitivity (UHS-M) imaging were examined. For CNR analysis, four different activity ranges representing low- and high-count settings were investigated for all three collimators. The experiments for the performance assessment were repeated with the same GP-M collimator in the three-detector U-SPECT\(^+\) for comparison. Results Peak sensitivity was 237 cps/MBq (XUHR-M), 847 cps/MBq (GP-M), 2054 cps/MBq (UHS-M) for U-SPECT5-E and 1710 cps/MBq (GP-M) for U-SPECT\(^+\). In the visually analysed sections of the reconstructed mini Derenzo phantoms, rods as small as 0.35 mm (XUHR-M), 0.50 mm (GP-M) for the two-detector as well as the three-detector SPECT and 0.75 mm (UHS-M) were resolved. Uniformity for maximum resolution recorded 40.7% (XUHR-M), 29.1% (GP-M, U-SPECT5-E), 16.3% (GP-M, U-SPECT\(^+\)) and 23.0% (UHS-M), respectively. UHS-M reached highest CNR values for low-count images; for rods smaller than 0.45 mm, acceptable CNR was only achieved by XUHR-M. GP-M was superior for imaging rods sized from 0.60 to 1.50 mm for intermediate activity concentrations. U-SPECT5-E and U-SPECT+ both provided comparable CNR. Conclusions While uniformity and sensitivity are negatively affected by the absence of a third detector, the investigated U-SPECT5-E system with two stationary detectors delivers excellent spatial resolution and CNR comparable to the performance of an established three-detector-setup. KW - small-animal imaging KW - SPECT KW - mouse KW - ollimator KW - post-reconstruction filtering Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-230361 VL - 7 ER - TY - JOUR A1 - Oorschot, Birgitt van A1 - Ishii, Koji A1 - Kusomoto, Yuko A1 - Zetzl, Theresa A1 - Roch, Carmen A1 - Mettenleiter, Andreas A1 - Ozawa, Hiroko A1 - Flentje, Michael T1 - Anxiety, depression and psychosocial needs are the most frequent concerns reported by patients: preliminary results of a comparative explorative analysis of two hospital-based palliative care teams in Germany and Japan JF - Journal of Neural Transmission N2 - In the partnership between the medical departments of Würzburg University, Germany, and Nagasaki University, Japan, palliative care is a relevant topic. The aim of the study was to perform a comparative analysis of the hospital-based palliative care teams in Würzburg (PCT-W) and Nagasaki (PCT-N). Survey of staff composition and retrospective analysis of PCT patient charts in both PCTs were conducted. Patients self-assessed their symptoms in PCT-W and in Radiation Oncology Würzburg (RO-W). The (negative) quality indicator ‘percentage of deceased hospitalised patients with PCT contact for less than 3 days before death’ (Earle in Int J Qual Health Care 17(6):505–509, 2005) was analysed. Both PCTs follow a multidisciplinary team approach. PCT-N saw 410 cancer patients versus 853 patients for PCT-W (22.8% non-cancer patients). The Eastern Cooperative Oncology Group Performance Status at first contact with PCT-N was 3 or 4 in 39.3% of patients versus 79.0% for PCT-W. PCT-N was engaged in co-management longer than PCT-W (mean 20.7 days, range 1–102 versus mean 4.9 days, range 1–48). The most frequent patient-reported psychological symptom was anxiety (family anxiety: 98.3% PCT-W and 88.7% RO-W, anxiety 97.9% PCT-W and 85.9% RO-W), followed by depression (98.2% PCT-W and 80.3% RO-W). In 14 of the 148 deceased patients, PCT-N contact was initiated less than 3 days before death (9.4%) versus 121 of the 729 deceased PCT-W patients (16.6%). Psychological needs are highly relevant in both Germany and Japan, with more than 85% anxiety and depression in patients in the Japanese IPOS validation study (Sakurai in Jpn J Clin Oncol 49(3):257–262, 2019). This should be taken into account when implementing PCTs. KW - hospital-based palliative care KW - patient-reported outcome KW - quaility indicator KW - anxiety KW - depression Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-235675 SN - 0300-9564 VL - 127 ER - TY - JOUR A1 - Vollmuth, Christoph A1 - Muljukov, Olga A1 - Abu-Mugheisib, Mazen A1 - Angermeier, Anselm A1 - Barlinn, Jessica A1 - Busetto, Loraine A1 - Grau, Armin J. A1 - Günther, Albrecht A1 - Gumbinger, Christoph A1 - Hubert, Nikolai A1 - Hüttemann, Katrin A1 - Klingner, Carsten A1 - Naumann, Markus A1 - Palm, Frederick A1 - Remi, Jan A1 - Rücker, Viktoria A1 - Schessl, Joachim A1 - Schlachetzki, Felix A1 - Schuppner, Ramona A1 - Schwab, Stefan A1 - Schwartz, Andreas A1 - Trommer, Adrian A1 - Urbanek, Christian A1 - Volbers, Bastian A1 - Weber, Joachim A1 - Wojciechowski, Claudia A1 - Worthmann, Hans A1 - Zickler, Philipp A1 - Heuschmann, Peter U. A1 - Haeusler, Karl Georg A1 - Hubert, Gordian Jan T1 - Impact of the coronavirus disease 2019 pandemic on stroke teleconsultations in Germany in the first half of 2020 JF - European Journal of Neurology N2 - Background and purpose The effects of the coronavirus disease 2019 (COVID-19) pandemic on telemedical care have not been described on a national level. Thus, we investigated the medical stroke treatment situation before, during, and after the first lockdown in Germany. Methods In this nationwide, multicenter study, data from 14 telemedical networks including 31 network centers and 155 spoke hospitals covering large parts of Germany were analyzed regarding patients' characteristics, stroke type/severity, and acute stroke treatment. A survey focusing on potential shortcomings of in-hospital and (telemedical) stroke care during the pandemic was conducted. Results Between January 2018 and June 2020, 67,033 telemedical consultations and 38,895 telemedical stroke consultations were conducted. A significant decline of telemedical (p < 0.001) and telemedical stroke consultations (p < 0.001) during the lockdown in March/April 2020 and a reciprocal increase after relaxation of COVID-19 measures in May/June 2020 were observed. Compared to 2018–2019, neither stroke patients' age (p = 0.38), gender (p = 0.44), nor severity of ischemic stroke (p = 0.32) differed in March/April 2020. Whereas the proportion of ischemic stroke patients for whom endovascular treatment (14.3% vs. 14.6%; p = 0.85) was recommended remained stable, there was a nonsignificant trend toward a lower proportion of recommendation of intravenous thrombolysis during the lockdown (19.0% vs. 22.1%; p = 0.052). Despite the majority of participating network centers treating patients with COVID-19, there were no relevant shortcomings reported regarding in-hospital stroke treatment or telemedical stroke care. Conclusions Telemedical stroke care in Germany was able to provide full service despite the COVID-19 pandemic, but telemedical consultations declined abruptly during the lockdown period and normalized after relaxation of COVID-19 measures in Germany. KW - COVID-19 KW - SARS-CoV- 2 KW - stroke KW - telemedicine KW - survey Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-259396 VL - 28 IS - 10 ER - TY - JOUR A1 - Mieszczanek, Pawel A1 - Robinson, Thomas M. A1 - Dalton, Paul D. A1 - Hutmacher, Dietmar W. T1 - Convergence of Machine Vision and Melt Electrowriting JF - Advanced Materials N2 - Melt electrowriting (MEW) is a high-resolution additive manufacturing technology that balances multiple parametric variables to arrive at a stable fabrication process. The better understanding of this balance is underscored here using high-resolution camera vision of jet stability profiles in different electrical fields. Complementing this visual information are fiber-diameter measurements obtained at precise points, allowing the correlation to electrified jet properties. Two process signatures—the jet angle and for the first time, the Taylor cone area—are monitored and analyzed with a machine vision system, while SEM imaging for diameter measurement correlates real-time information. This information, in turn, allows the detection and correction of fiber pulsing for accurate jet placement on the collector, and the in-process assessment of the fiber diameter. Improved process control is used to successfully fabricate collapsible MEW tubes; structures that require exceptional accuracy and printing stability. Using a precise winding angle of 60° and 300 layers, the resulting 12 mm-thick tubular structures have elastic snap-through instabilities associated with mechanical metamaterials. This study provides a detailed analysis of the fiber pulsing occurrence in MEW and highlights the importance of real-time monitoring of the Taylor cone volume to better understand, control, and predict printing instabilities. KW - polycaprolactone KW - 3D printing KW - digitization KW - electrohydrodynamic KW - melt electrospinning writing Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-256365 VL - 33 IS - 29 ER - TY - JOUR A1 - Wajant, Harald T1 - Molecular mode of action of TRAIL receptor agonists—common principles and their translational exploitation JF - Cancers N2 - Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its death receptors TRAILR1/death receptor 4 (DR4) and TRAILR2/DR5 trigger cell death in many cancer cells but rarely exert cytotoxic activity on non-transformed cells. Against this background, a variety of recombinant TRAIL variants and anti-TRAIL death receptor antibodies have been developed and tested in preclinical and clinical studies. Despite promising results from mice tumor models, TRAIL death receptor targeting has failed so far in clinical studies to show satisfying anti-tumor efficacy. These disappointing results can largely be explained by two issues: First, tumor cells can acquire TRAIL resistance by several mechanisms defining a need for combination therapies with appropriate sensitizing drugs. Second, there is now growing preclinical evidence that soluble TRAIL variants but also bivalent anti-TRAIL death receptor antibodies typically require oligomerization or plasma membrane anchoring to achieve maximum activity. This review discusses the need for oligomerization and plasma membrane attachment for the activity of TRAIL death receptor agonists in view of what is known about the molecular mechanisms of how TRAIL death receptors trigger intracellular cell death signaling. In particular, it will be highlighted which consequences this has for the development of next generation TRAIL death receptor agonists and their potential clinical application. KW - antibody KW - antibody fusion proteins KW - apoptosis KW - cancer therapy KW - cell death KW - death receptors KW - TNF superfamily KW - TNF receptor superfamily KW - TRAIL Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-201833 N1 - Zugriff gesperrt. Zugriff auf den Volltext erhalten Sie unter https://nbn-resolving.org/urn:nbn:de:bvb:20-opus-202416 VL - 11 IS - 7 ER - TY - JOUR A1 - Peseschkian, Tara A1 - Cordts, Isabell A1 - Günther, René A1 - Stolte, Benjamin A1 - Zeller, Daniel A1 - Schröter, Carsten A1 - Weyen, Ute A1 - Regensburger, Martin A1 - Wolf, Joachim A1 - Schneider, Ilka A1 - Hermann, Andreas A1 - Metelmann, Moritz A1 - Kohl, Zacharias A1 - Linker, Ralf A. A1 - Koch, Jan Christoph A1 - Büchner, Boriana A1 - Weiland, Ulrike A1 - Schönfelder, Erik A1 - Heinrich, Felix A1 - Osmanovic, Alma A1 - Klopstock, Thomas A1 - Dorst, Johannes A1 - Ludolph, Albert C. A1 - Boentert, Matthias A1 - Hagenacker, Tim A1 - Deschauer, Marcus A1 - Lingor, Paul A1 - Petri, Susanne A1 - Schreiber-Katz, Olivia T1 - A nation-wide, multi-center study on the quality of life of ALS patients in Germany JF - Brain Sciences N2 - Improving quality of life (QoL) is central to amyotrophic lateral sclerosis (ALS) treatment. This Germany-wide, multicenter cross-sectional study analyses the impact of different symptom-specific treatments and ALS variants on QoL. Health-related QoL (HRQoL) in 325 ALS patients was assessed using the Amyotrophic Lateral Sclerosis Assessment Questionnaire 5 (ALSAQ-5) and EuroQol Five Dimension Five Level Scale (EQ-5D-5L), together with disease severity (captured by the revised ALS Functional Rating Scale (ALSFRS-R)) and the current care and therapies used by our cohort. At inclusion, the mean ALSAQ-5 total score was 56.93 (max. 100, best = 0) with a better QoL associated with a less severe disease status (β = −1.96 per increase of one point in the ALSFRS-R score, p < 0.001). “Limb-onset” ALS (lALS) was associated with a better QoL than “bulbar-onset” ALS (bALS) (mean ALSAQ-5 total score 55.46 versus 60.99, p = 0.040). Moreover, with the ALSFRS-R as a covariate, using a mobility aid (β = −7.60, p = 0.001), being tracheostomized (β = −14.80, p = 0.004) and using non-invasive ventilation (β = −5.71, p = 0.030) were associated with an improved QoL, compared to those at the same disease stage who did not use these aids. In contrast, antidepressant intake (β = 5.95, p = 0.007), and increasing age (β = 0.18, p = 0.023) were predictors of worse QoL. Our results showed that the ALSAQ-5 was better-suited for ALS patients than the EQ-5D-5L. Further, the early and symptom-specific clinical management and supply of assistive devices can significantly improve the individual HRQoL of ALS patients. Appropriate QoL questionnaires are needed to monitor the impact of treatment to provide the best possible and individualized care. KW - Amyotrophic Lateral Sclerosis (ALS) KW - Amyotrophic Lateral Sclerosis Assessment Questionnaire 5 (ALSAQ-5) KW - ALS treatment KW - “bulbar-onset” ALS (bALS) KW - “limb-onset” ALS (lALS) KW - EuroQol Five Dimension Five Level Scale (EQ-5D-5L) KW - health-related quality of life (HRQoL) KW - quality of life (QoL) KW - symptom-specific treatment KW - assistive devices Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-234147 SN - 2076-3425 VL - 11 IS - 3 ER - TY - JOUR A1 - Detomas, Mario A1 - Altieri, Barbara A1 - Schlötelburg, Wiebke A1 - Appenzeller, Silke A1 - Schlaffer, Sven A1 - Coras, Roland A1 - Schirbel, Andreas A1 - Wild, Vanessa A1 - Kroiss, Matthias A1 - Sbiera, Silviu A1 - Fassnacht, Martin A1 - Deutschbein, Timo T1 - Case Report: Consecutive Adrenal Cushing’s Syndrome and Cushing’s Disease in a Patient With Somatic CTNNB1, USP8, and NR3C1 Mutations JF - Frontiers in Endocrinology N2 - The occurrence of different subtypes of endogenous Cushing’s syndrome (CS) in single individuals is extremely rare. We here present the case of a female patient who was successfully cured from adrenal CS 4 years before being diagnosed with Cushing’s disease (CD). The patient was diagnosed at the age of 50 with ACTH-independent CS and a left-sided adrenal adenoma, in January 2015. After adrenalectomy and histopathological confirmation of a cortisol-producing adrenocortical adenoma, biochemical hypercortisolism and clinical symptoms significantly improved. However, starting from 2018, the patient again developed signs and symptoms of recurrent CS. Subsequent biochemical and radiological workup suggested the presence of ACTH-dependent CS along with a pituitary microadenoma. The patient underwent successful transsphenoidal adenomectomy, and both postoperative adrenal insufficiency and histopathological workup confirmed the diagnosis of CD. Exome sequencing excluded a causative germline mutation but showed somatic mutations of the β-catenin protein gene (CTNNB1) in the adrenal adenoma, and of both the ubiquitin specific peptidase 8 (USP8) and the glucocorticoid receptor (NR3C1) genes in the pituitary adenoma. In conclusion, our case illustrates that both ACTH-independent and ACTH-dependent CS may develop in a single individual even without evidence for a common genetic background. KW - Cushing’s syndrome KW - Cushing’s disease KW - hypercortisolism KW - glucocorticoid excess KW - USP8 KW - CTNNB1 KW - NR3C1 Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-244596 SN - 1664-2392 VL - 12 ER - TY - JOUR A1 - Lassmann, Michael A1 - Eberlein, Uta T1 - Comparing absorbed doses and radiation risk of the α-emitting bone-seekers [\(^{223}\)Ra]RaCl\(_2\) and [\(^{224}\)Ra]RaCl\(_2\) JF - Frontiers in Medicine N2 - [\(^{223}\)Ra]RaCl\(_2\) and [\(^{224}\)Ra]RaCl\(_2\) are bone seekers, emitting high LET, and short range (< 100 μm) alpha-particles. Both radionuclides show similar decay properties; the total alpha energies are comparable (\(^{223}\)Ra: ≈28 MeV, \(^{224}\)Ra: ≈26 MeV). [\(^{224}\)Ra]RaCl\(_2\) has been used from the mid-1940s until 1990 for treating different bone and joint diseases with activities of up to approximately 50 MBq [\(^{224}\)Ra]RaCl\(_2\). In 2013 [\(^{223}\)Ra]RaCl\(_2\) obtained marketing authorization by the FDA and by the European Union for the treatment of metastatic prostate cancer with an activity to administer of 0.055 MBq per kg body weight for six cycles. For intravenous injections in humans a model calculation using the biokinetic model of ICRP67 shows a ratio of organ absorbed dose coefficients (\(^{224}\)Ra:\(^{223}\)Ra) between 0.37 (liver) and 0.97 except for the kidneys (2.27) and blood (1.57). For the red marrow as primary organ-at-risk, the ratio is 0.57. The differences are mainly caused be the differing half-lives of the decay products of both radium isotopes. Both radionuclides show comparable DNA damage patterns in peripheral blood mononuclear cells after internal ex-vivo irradiation. Data on the long-term radiation-associated side effects are only available for treatment with [\(^{224}\)Ra]RaCl\(_2\). Two epidemiological studies followed two patient groups treated with [\(^{224}\)Ra]RaCl\(_2\) for more than 25 years. One of them was the “Spiess study”, a cohort of 899 juvenile patients who received several injections of [\(^{224}\)Ra]RaCl\(_2\) with a mean specific activity of 0.66 MBq/kg. Another patient group of ankylosing spondylitis patients was treated with 10 repeated intravenous injections of [\(^{224}\)Ra]RaCl\(_2\), 1 MBq each, 1 week apart. In total 1,471 of these patients were followed-up in the “Wick study”. In both studies, an increased cancer mortality by leukemia and solid cancers was observed. Similar considerations on long-term effects likely apply to [\(^{223}\)Ra]RaCl\(_2\) as well since the biokinetics are similar and the absorbed doses in the same range. However, this increased risk will most likely not be observed due to the much shorter life expectancy of prostate cancer patients treated with [\(^{223}\)Ra]RaCl\(_2\). KW - dosimetry KW - biodosimetry KW - 224Ra KW - 223Ra KW - epidemiology Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-301509 SN - 2296-858X VL - 9 ER - TY - JOUR A1 - Zhou, Xiang A1 - Ruckdeschel, Anna A1 - Peter, Jessica A1 - Böckle, David A1 - Hornburger, Hannah A1 - Danhof, Sophia A1 - Steinhardt, Maximilian Johannes A1 - Heimeshoff, Larissa A1 - Einsele, Hermann A1 - Kortüm, Klaus Martin A1 - Rasche, Leo T1 - Salvage therapy with "Dara-KDT-P(A)CE" in heavily pretreated, high-risk, proliferative, relapsed/refractory multiple myeloma JF - Hematological Oncology N2 - The multi-agent therapy “VDT-PACE” represents an established regimen in relapsed/refractory multiple myeloma (RRMM). Here, we report on our experience with a “modified VDT-PACE” incorporating new generation anti-MM agents daratumumab and carfilzomib (“Dara-KDT-P(A)CE”). We retrospectively analyzed 38 patients with RRMM treated with “Dara-KDT-P(A)CE”. The median age was 62 (range 45–82) years, and the patients were heavily pretreated with a median of 5 (range 2–12) prior lines of therapy. Twenty-one (55%) patients suffered from penta-refractory MM. High-risk cytogenetics was present in 31 (81%) patients. The patients received a median of 2 (range 1–10) cycles of this therapy, and the overall response rate (ORR) was 70%. Patients with penta-refractory MM and high-risk cytogenetics showed similar ORR of 65% and 79%, respectively. The median progression-free survival (PFS) and overall survival were 4.1 (95% CI 2.7–5.4) and 8.4 (95% CI 6.7–10.0) months, respectively. Patients with lactate dehydrogenase >250 IU/L showed significantly shorter PFS in comparison with others patients (p = 0.006). We used this regimen as bridging therapy prior to chimeric antigen receptor T-cell infusion in four patients. In conclusion, “Dara-KDT-P(A)CE” is an effective salvage therapy for patients with heavily pretreated, multi-refractory, high-risk RRMM lacking alternative options. KW - Dara-KDT-P(A)CE KW - multiple myeloma KW - refractory KW - salvage Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-257495 VL - 40 IS - 2 ER - TY - JOUR A1 - Kremer, Naomi I. A1 - Pauwels, Rik W. J. A1 - Pozzi, Nicolò G. A1 - Lange, Florian A1 - Roothans, Jonas A1 - Volkmann, Jens A1 - Reich, Martin M. T1 - Deep Brain Stimulation for Tremor: Update on Long-Term Outcomes, Target Considerations and Future Directions JF - Journal of Clinical Medicine N2 - Deep brain stimulation (DBS) of the thalamic ventral intermediate nucleus is one of the main advanced neurosurgical treatments for drug-resistant tremor. However, not every patient may be eligible for this procedure. Nowadays, various other functional neurosurgical procedures are available. In particular cases, radiofrequency thalamotomy, focused ultrasound and radiosurgery are proven alternatives to DBS. Besides, other DBS targets, such as the posterior subthalamic area (PSA) or the dentato-rubro-thalamic tract (DRT), may be appraised as well. In this review, the clinical characteristics and pathophysiology of tremor syndromes, as well as long-term outcomes of DBS in different targets, will be summarized. The effectiveness and safety of lesioning procedures will be discussed, and an evidence-based clinical treatment approach for patients with drug-resistant tremor will be presented. Lastly, the future directions in the treatment of severe tremor syndromes will be elaborated. KW - deep brain stimulation KW - tremor KW - essential tremor KW - Parkinson’s disease KW - outcomes KW - clinical approach KW - target considerations KW - future directions Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-244982 SN - 2077-0383 VL - 10 IS - 16 ER - TY - JOUR A1 - De Lira, Maria Nathalia A1 - Raman, Sudha Janaki A1 - Schulze, Almut A1 - Schneider-Schaulies, Sibylle A1 - Avota, Elita T1 - Neutral Sphingomyelinase-2 (NSM 2) Controls T Cell Metabolic Homeostasis and Reprogramming During Activation JF - Frontiers in Molecular Biosciences N2 - Neutral sphingomyelinase-2 (NSM2) is a member of a superfamily of enzymes responsible for conversion of sphingomyelin into phosphocholine and ceramide at the cytosolic leaflet of the plasma membrane. Upon specific ablation of NSM2, T cells proved to be hyper-responsive to CD3/CD28 co-stimulation, indicating that the enzyme acts to dampen early overshooting activation of these cells. It remained unclear whether hyper-reactivity of NSM2-deficient T cells is supported by a deregulated metabolic activity in these cells. Here, we demonstrate that ablation of NSM2 activity affects metabolism of the quiescent CD4\(^+\) T cells which accumulate ATP in mitochondria and increase basal glycolytic activity. This supports enhanced production of total ATP and metabolic switch early after TCR/CD28 stimulation. Most interestingly, increased metabolic activity in resting NSM2-deficient T cells does not support sustained response upon stimulation. While elevated under steady-state conditions in NSM2-deficient CD4\(^+\) T cells, the mTORC1 pathway regulating mitochondria size, oxidative phosphorylation, and ATP production is impaired after 24 h of stimulation. Taken together, the absence of NSM2 promotes a hyperactive metabolic state in unstimulated CD4\(^+\) T cells yet fails to support sustained T cell responses upon antigenic stimulation. KW - neutral sphingomyelinase-2 KW - T cell receptor KW - Seahorse XF KW - oxidative phosphorylation KW - ATP-adenosine triphosphate KW - Mitochondria Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-211311 SN - 2296-889X VL - 7 ER - TY - JOUR A1 - Sancho, Ana A1 - Vandersmissen, Ine A1 - Craps, Sander A1 - Luttun, Aernout A1 - Groll, Jürgen T1 - A new strategy to measure intercellular adhesion forces in mature cell-cell contacts JF - Scientific Reports N2 - Intercellular adhesion plays a major role in tissue development and homeostasis. Yet, technologies to measure mature cell-cell contacts are not available. We introduce a methodology based on fluidic probe force microscopy to assess cell-cell adhesion forces after formation of mature intercellular contacts in cell monolayers. With this method we quantify that L929 fibroblasts exhibit negligible cell-cell adhesion in monolayers whereas human endothelial cells from the umbilical artery (HUAECs) exert strong intercellular adhesion forces per cell. We use a new in vitro model based on the overexpression of Muscle Segment Homeobox 1 (MSX1) to induce Endothelial-to-Mesenchymal Transition (EndMT), a process involved in cardiovascular development and disease. We reveal how intercellular adhesion forces in monolayer decrease significantly at an early stage of EndMT and we show that cells undergo stiffening and flattening at this stage. This new biomechanical insight complements and expands the established standard biomolecular analyses. Our study thus introduces a novel tool for the assessment of mature intercellular adhesion forces in a physiological setting that will be of relevance to biological processes in developmental biology, tissue regeneration and diseases like cancer and fibrosis. KW - intercellular adhesion KW - mature cell-cell contacts KW - atomic force microscopy KW - biophysics Y1 - 2017 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-170999 VL - 7 IS - 46152 ER - TY - JOUR A1 - Yu, Sung-Huan A1 - Vogel, Jörg A1 - Förstner, Konrad U. T1 - ANNOgesic: a Swiss army knife for the RNA-seq based annotation of bacterial/archaeal genomes JF - GigaScience N2 - To understand the gene regulation of an organism of interest, a comprehensive genome annotation is essential. While some features, such as coding sequences, can be computationally predicted with high accuracy based purely on the genomic sequence, others, such as promoter elements or noncoding RNAs, are harder to detect. RNA sequencing (RNA-seq) has proven to be an efficient method to identify these genomic features and to improve genome annotations. However, processing and integrating RNA-seq data in order to generate high-resolution annotations is challenging, time consuming, and requires numerous steps. We have constructed a powerful and modular tool called ANNOgesic that provides the required analyses and simplifies RNA-seq-based bacterial and archaeal genome annotation. It can integrate data from conventional RNA-seq and differential RNA-seq and predicts and annotates numerous features, including small noncoding RNAs, with high precision. The software is available under an open source license (ISCL) at https://pypi.org/project/ANNOgesic/. KW - genome annotation KW - RNA-seq KW - transcriptomics Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-178942 VL - 7 ER - TY - JOUR A1 - Martinez-Bengochea, A. L. A1 - Kneitz, S. A1 - Herpin, A. A1 - Nobrega, R. H. A1 - Adolfi, M. C. A1 - Schartl, M. T1 - Sexual development dysgenesis in interspecific hybrids of Medaka fish JF - Scientific Reports N2 - Fish are amongst vertebrates the group with the highest diversity of known sex-determining genes. Particularly, the genus Oryzias is a suitable taxon to understand how different sex determination genetic networks evolved in closely related species. Two closely related species, O. latipes and O. curvinotus, do not only share the same XX/XY sex chromosome system, but also the same male sex-determining gene, dmrt1bY. We performed whole mRNA transcriptomes and morphology analyses of the gonads of hybrids resulting from reciprocal crosses between O. latipes and O. curvinotus. XY male hybrids, presenting meiotic arrest and no production of sperm were sterile, and about 30% of the XY hybrids underwent male-to-female sex reversal. Both XX and XY hybrid females exhibited reduced fertility and developed ovotestis while aging. Transcriptome data showed that male-related genes are upregulated in the XX and XY female hybrids. The transcriptomes of both types of female and of the male gonads are characterized by upregulation of meiosis and germ cell differentiation genes. Differences in the parental species in the downstream pathways of sexual development could explain sex reversal, sterility, and the development of intersex gonads in the hybrids. We hypothesize that male-to-female sex reversal may be connected to a different development time between species at which dmrt1bY expression starts. Our results provide molecular clues for the proximate mechanisms of hybrid incompatibility and Haldane’s rule. KW - sexual development dysgenesis KW - Medaka fish KW - sex-determining genes. Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-300295 VL - 12 IS - 1 ER - TY - JOUR A1 - Hintzsche, Henning A1 - Montag, Gracia A1 - Stopper, Helga T1 - Induction of micronuclei by four cytostatic compounds in human hematopoietic stem cells and human lymphoblastoid TK6 cells JF - Scientific Reports N2 - For mutagenicity testing, primary lymphocytes or mammalian cell lines are employed. However, the true target for carcinogenic action of mutagenic chemicals may be stem cells. Since hematopoietic cancers induced by chemical agents originate at the hematopoietic stem cell (HSC) stage and since one of the side effects of chemotherapeutic cancer treatment is the induction of secondary tumors, often leukemias, HSC may be a suitable cell system. We compared the sensitivity of HSC with the genotoxicity testing cell line TK6 for chromosomal mutations. HSC were less sensitive than TK6 cells for the genotoxic effects of the model genotoxins and chemotherapeutic agents doxorubicin, vinblastine, methyl methanesulfonate (MMS) and equally sensitive for mitomycin C (MMC). However, loss of viability after mitomycin C treatment was higher in HSC than in TK6 cells. Among the factors that may influence sensitivity for genomic damage, the generation or response to reactive oxygen species (ROS) and the effectiveness of DNA damage response can be discussed. Here we show that HSC can be used in a standard micronucleus test protocol for chromosomal mutations and that their sensitivity was not higher than that of a classical testing cell line. KW - apoptosis KW - haematopoietic stem cells KW - TK6 cells KW - micronuclei Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-176210 VL - 8 IS - 3371 ER - TY - JOUR A1 - Solimando, Antonio Giovanni A1 - Da Vià, Matteo Claudio A1 - Bolli, Niccolò A1 - Steinbrunn, Torsten T1 - The route of the malignant plasma cell in its survival niche: exploring “Multiple Myelomas” JF - Cancers N2 - Growing evidence points to multiple myeloma (MM) and its stromal microenvironment using several mechanisms to subvert effective immune and anti-tumor responses. Recent advances have uncovered the tumor-stromal cell influence in regulating the immune-microenvironment and have envisioned targeting these suppressive pathways to improve therapeutic outcomes. Nevertheless, some subgroups of patients include those with particularly unfavorable prognoses. Biological stratification can be used to categorize patient-, disease- or therapy-related factors, or alternatively, these biological determinants can be included in a dynamic model that customizes a given treatment to a specific patient. Genetic heterogeneity and current knowledge enforce a systematic and comprehensive bench-to-bedside approach. Given the increasing role of cancer stem cells (CSCs) in better characterizing the pathogenesis of solid and hematological malignancies, disease relapse, and drug resistance, identifying and describing CSCs is of paramount importance in the management of MM. Even though the function of CSCs is well-known in other cancer types, their role in MM remains elusive. With this review, we aim to provide an update on MM homing and resilience in the bone marrow micro milieu. These data are particularly interesting for clinicians facing unmet medical needs while designing novel treatment approaches for MM. KW - multiple myeloma KW - cell of origin KW - cancer stem cells KW - bone marrow homing KW - adhesion molecule KW - bone marrow immune-microenvironment Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-281728 SN - 2072-6694 VL - 14 IS - 13 ER - TY - JOUR A1 - Hanitsch, Leif A1 - Baumann, Ulrich A1 - Boztug, Kaan A1 - Burkhard‐Meier, Ulrike A1 - Fasshauer, Maria A1 - Habermehl, Pirmin A1 - Hauck, Fabian A1 - Klock, Gerd A1 - Liese, Johannes A1 - Meyer, Oliver A1 - Müller, Rainer A1 - Pachlopnik‐Schmid, Jana A1 - Pfeiffer‐Kascha, Dorothea A1 - Warnatz, Klaus A1 - Wehr, Claudia A1 - Wittke, Kirsten A1 - Niehues, Tim A1 - von Bernuth, Horst T1 - Treatment and management of primary antibody deficiency: German interdisciplinary evidence‐based consensus guideline JF - European Journal of Immunology N2 - This evidence‐based clinical guideline provides consensus‐recommendations for the treatment and care of patients with primary antibody deficiencies (PADs). The guideline group comprised 20 clinical and scientific expert associations of the German, Swiss, and Austrian healthcare system and representatives of patients. Recommendations were based on results of a systematic literature search, data extraction, and evaluation of methodology and study quality in combination with the clinical expertise of the respective representatives. Consensus‐based recommendations were determined via nominal group technique. PADs are the largest clinically relevant group of primary immunodeficiencies. Most patients with PADs present with increased susceptibility to infections, however immune dysregulation, autoimmunity, and cancer affect a significant number of patients and may precede infections. This guideline therefore covers interdisciplinary clinical and therapeutic aspects of infectious (e.g., antibiotic prophylaxis, management of bronchiectasis) and non‐infectious manifestations (e.g., management of granulomatous disease, immune cytopenia). PADs are grouped into disease entities with definitive, probable, possible, or unlikely benefit of IgG‐replacement therapy. Summary and consensus‐recommendations are provided for treatment indication, dosing, routes of administration, and adverse events of IgG‐replacement therapy. Special aspects of concomitant impaired T‐cell function are highlighted as well as clinical data on selected monogenetic inborn errors of immunity formerly classified into PADs (APDS, CTLA‐4‐, and LRBA‐deficiency). KW - autoimmunity KW - CVID KW - hypogammaglobulinemia KW - immunoglobulins KW - primary antibody deficiency Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-225731 VL - 50 IS - 10 SP - 1432 EP - 1446 ER - TY - JOUR A1 - Zhou, Yang A1 - Ding, Meiqi A1 - Duan, Xiaodong A1 - Konrad, Kai R. A1 - Nagel, Georg A1 - Gao, Shiqiang T1 - Extending the Anion Channelrhodopsin-Based Toolbox for Plant Optogenetics JF - Membranes N2 - Optogenetics was developed in the field of neuroscience and is most commonly using light-sensitive rhodopsins to control the neural activities. Lately, we have expanded this technique into plant science by co-expression of a chloroplast-targeted β-carotene dioxygenase and an improved anion channelrhodopsin GtACR1 from the green alga Guillardia theta. The growth of Nicotiana tabacum pollen tube can then be manipulated by localized green light illumination. To extend the application of analogous optogenetic tools in the pollen tube system, we engineered another two ACRs, GtACR2, and ZipACR, which have different action spectra, light sensitivity and kinetic features, and characterized them in Xenopus laevis oocytes, Nicotiana benthamiana leaves and N. tabacum pollen tubes. We found that the similar molecular engineering method used to improve GtACR1 also enhanced GtACR2 and ZipACR performance in Xenopus laevis oocytes. The ZipACR1 performed in N. benthamiana mesophyll cells and N. tabacum pollen tubes with faster kinetics and reduced light sensitivity, allowing for optogenetic control of anion fluxes with better temporal resolution. The reduced light sensitivity would potentially facilitate future application in plants, grown under low ambient white light, combined with an optogenetic manipulation triggered by stronger green light. KW - optogenetics KW - rhodopsin KW - light-sensitive anion channel KW - surface potential recording KW - pollen tube Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-236617 SN - 2077-0375 VL - 11 IS - 4 ER - TY - JOUR A1 - Hensgen, Ronja A1 - England, Laura A1 - Homberg, Uwe A1 - Pfeiffer, Keram T1 - Neuroarchitecture of the central complex in the brain of the honeybee: Neuronal cell types JF - Journal of Comparative Neurology N2 - The central complex (CX) in the insect brain is a higher order integration center that controls a number of behaviors, most prominently goal directed locomotion. The CX comprises the protocerebral bridge (PB), the upper division of the central body (CBU), the lower division of the central body (CBL), and the paired noduli (NO). Although spatial orientation has been extensively studied in honeybees at the behavioral level, most electrophysiological and anatomical analyses have been carried out in other insect species, leaving the morphology and physiology of neurons that constitute the CX in the honeybee mostly enigmatic. The goal of this study was to morphologically identify neuronal cell types of the CX in the honeybee Apis mellifera. By performing iontophoretic dye injections into the CX, we traced 16 subtypes of neuron that connect a subdivision of the CX with other regions in the bee's central brain, and eight subtypes that mainly interconnect different subdivisions of the CX. They establish extensive connections between the CX and the lateral complex, the superior protocerebrum and the posterior protocerebrum. Characterized neuron classes and subtypes are morphologically similar to those described in other insects, suggesting considerable conservation in the neural network relevant for orientation. KW - RRID: AB_2337244 KW - RRID: AB_2315425 KW - central complex KW - insect brain KW - neuroanatomy KW - sky compass KW - Apis mellifera Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-215566 VL - 529 ER - TY - JOUR A1 - Schlagenhauf, Ulrich A1 - Rehder, Juliane A1 - Gelbrich, Götz A1 - Jockel‐Schneider, Yvonne T1 - Consumption of Lactobacillus reuteri‐containing lozenges improves periodontal health in navy sailors at sea: A randomized controlled trial JF - Journal of Periodontology N2 - Background The objective of this trial was to evaluate whether the regular consumption of probiotics may improve the known deterioration of periodontal health in navy sailors during deployments at sea. Methods 72 healthy sailors of a naval ship on a practicing mission at sea were recruited and randomly provided with a blinded supply of lozenges to be consumed twice daily for the following 42 days containing either the probiotic strains Lactobacillus reuteri (DSM 17938 and L. reuteri (ATTC PTA 5289) (test n = 36) or no probiotics (placebo n = 36). At baseline, at day 14 and day 42 bleeding on probing (primary outcome), gingival index, plaque control record, probing attachment level, and probing pocket depth were assessed at the Ramfjord teeth. Results At baseline there were no significant differences between the groups. At day 14 and day 42 test group scores of all assessed parameters were significantly improved (P < 0.001) compared to baseline and to the placebo group which by contrast showed a significant (P < 0.001) deterioration of all parameters at the end of the study. Conclusions The consumption of probiotic L. reuteri‐lozenges is an efficacious measure to improve and maintain periodontal health in situations with waning efficacy of personal oral hygiene. KW - gingivitis KW - oral hygiene KW - probiotics Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-215577 VL - 91 IS - 10 SP - 1328 EP - 1338 ER - TY - JOUR A1 - Ruf, Katharina A1 - Demerath, Antonia A1 - Hebestreit, Helge A1 - Kunzmann, Steffen T1 - Is sweat testing for cystic fibrosis feasible in patients with down syndrome? JF - BMC Pulmonary Medicine N2 - Background: Recurrent airway infections are common in patients with Down's syndrome (DS). Hence, ruling out Cystic Fibrosis (CF) in these patients is often required. In the past, the value of sweat testing the gold standard to diagnose CF -has been questioned in DS as false positive results have been reported. However, these reports are based on measurements of sweat osmolality or sodium concentrations, not chloride concentrations. This study analyses sweat secretion rate and chloride concentration in sweat samples of patients with DS in comparison to healthy controls. Methods: We assessed sweat samples in 16 patients with DS and 16 healthy controls regarding sweat secretion rate (SSR) and sweat chloride concentration. Results: All measured chloride concentrations were within the normal range. The chloride concentrations were slightly, but not significantly lower in patients with DS (15,54 mmol/l (±4,47)) compared to healthy controls (18,31 mmol/l (±10,12)). While no gender gap in chloride concentration could be found, chloride concentration increased with age in both groups. Insufficient sweat was collected in 2 females with DS (12.5% of the study group) but not in an individual of the control group. A significant lower sweat secretion rate was found in the DS group (27,6 μl/30 min (± 12,18)) compared to the control group (42,7 μl/30 min (± 21,22)). In a sub-analysis, female patients produced significantly less sweat (20,8 ± 10,6 μl/30 min) than male patients with DS (36,4 ± 7,8 μl/30 min), which accounts for the difference between patients and controls. Furthermore, while the sweating secretion rate increased with age in the control group, it did not do so in the DS group. Once again this was due to female patients with DS, who did not show a significant increase of sweat secretion rate with age. Conclusions: Sweat chloride concentrations were within the normal range in patients with DS and therefore seem to be a reliable tool for testing for CF in these patients. Interestingly, we found a reduced sweat secretion rate in the DS group. Whether the last one has a functional and clinical counterpart, possibly due to a disturbed thermoregulation in DS patients, requires further investigation. KW - sweat secretion rate KW - sweat osmolality KW - gender gap KW - non-responder KW - thermoregulation Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-175519 VL - 18 IS - 8 ER - TY - JOUR A1 - Samper Agrelo, Iria A1 - Schira-Heinen, Jessica A1 - Beyer, Felix A1 - Groh, Janos A1 - Bütermann, Christine A1 - Estrada, Veronica A1 - Poschmann, Gereon A1 - Bribian, Ana A1 - Jadasz, Janusz J. A1 - Lopez-Mascaraque, Laura A1 - Kremer, David A1 - Martini, Rudolf A1 - Müller, Hans Werner A1 - Hartung, Hans Peter A1 - Adjaye, James A1 - Stühler, Kai A1 - Küry, Patrick T1 - Secretome analysis of mesenchymal stem cell factors fostering oligodendroglial differentiation of neural stem cells in vivo JF - International Journal of Molecular Sciences N2 - Mesenchymal stem cell (MSC)-secreted factors have been shown to significantly promote oligodendrogenesis from cultured primary adult neural stem cells (aNSCs) and oligodendroglial precursor cells (OPCs). Revealing underlying mechanisms of how aNSCs can be fostered to differentiate into a specific cell lineage could provide important insights for the establishment of novel neuroregenerative treatment approaches aiming at myelin repair. However, the nature of MSC-derived differentiation and maturation factors acting on the oligodendroglial lineage has not been identified thus far. In addition to missing information on active ingredients, the degree to which MSC-dependent lineage instruction is functional in vivo also remains to be established. We here demonstrate that MSC-derived factors can indeed stimulate oligodendrogenesis and myelin sheath generation of aNSCs transplanted into different rodent central nervous system (CNS) regions, and furthermore, we provide insights into the underlying mechanism on the basis of a comparative mass spectrometry secretome analysis. We identified a number of secreted proteins known to act on oligodendroglia lineage differentiation. Among them, the tissue inhibitor of metalloproteinase type 1 (TIMP-1) was revealed to be an active component of the MSC-conditioned medium, thus validating our chosen secretome approach. KW - neural stem cells KW - mesenchymal stem cells KW - transplantation KW - oligodendroglia KW - glial fate modulation KW - myelin KW - spinal cord KW - secretome KW - TIMP-1 Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-285465 SN - 1422-0067 VL - 21 IS - 12 ER - TY - JOUR A1 - Schapovalova, Olesia A1 - Gorlova, Anna A1 - de Munter, Johannes A1 - Sheveleva, Elisaveta A1 - Eropkin, Mikhail A1 - Gorbunov, Nikita A1 - Sicker, Michail A1 - Umriukhin, Aleksei A1 - Lyubchyk, Sergiy A1 - Lesch, Klaus-Peter A1 - Strekalova, Tatyana A1 - Schroeter, Careen A. T1 - Immunomodulatory effects of new phytotherapy on human macrophages and TLR4- and TLR7/8-mediated viral-like inflammation in mice JF - Frontiers in Medicine N2 - Background While all efforts have been undertaken to propagate the vaccination and develop remedies against SARS-CoV-2, no satisfactory management of this infection is available yet. Moreover, poor availability of any preventive and treatment measures of SARS-CoV-2 in economically disadvantageous communities aggravates the course of the pandemic. Here, we studied a new immunomodulatory phytotherapy (IP), an extract of blackberry, chamomile, garlic, cloves, and elderberry as a potential low-cost solution for these problems given the reported efficacy of herbal medicine during the previous SARS virus outbreak. Methods The key feature of SARS-CoV-2 infection, excessive inflammation, was studied in in vitro and in vivo assays under the application of the IP. First, changes in tumor-necrosis factor (TNF) and lnteurleukin-1 beta (IL-1β) concentrations were measured in a culture of human macrophages following the lipopolysaccharide (LPS) challenge and treatment with IP or prednisolone. Second, chronically IP-pre-treated CD-1 mice received an agonist of Toll-like receptors (TLR)-7/8 resiquimod and were examined for lung and spleen expression of pro-inflammatory cytokines and blood formula. Finally, chronically IP-pre-treated mice challenged with LPS injection were studied for “sickness” behavior. Additionally, the IP was analyzed using high-potency-liquid chromatography (HPLC)-high-resolution-mass-spectrometry (HRMS). Results LPS-induced in vitro release of TNF and IL-1β was reduced by both treatments. The IP-treated mice displayed blunted over-expression of SAA-2, ACE-2, CXCL1, and CXCL10 and decreased changes in blood formula in response to an injection with resiquimod. The IP-treated mice injected with LPS showed normalized locomotion, anxiety, and exploration behaviors but not abnormal forced swimming. Isoquercitrin, choline, leucine, chlorogenic acid, and other constituents were identified by HPLC-HRMS and likely underlie the IP immunomodulatory effects. Conclusions Herbal IP-therapy decreases inflammation and, partly, “sickness behavior,” suggesting its potency to combat SARS-CoV-2 infection first of all via its preventive effects. KW - toll-like receptors KW - SARS-CoV-2 KW - inflammation KW - pro-inflammatory cytokines KW - mice Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-286301 SN - 2296-858X VL - 9 ER - TY - GEN A1 - Tort, Jose F. A1 - Mitreva, Makedonka A1 - Brehm, Klaus R. A1 - Rinaldi, Gabriel T1 - Editorial: Novel Frontiers in Helminth Genomics T2 - Frontiers in Genetics N2 - No abstract available. KW - flatworm KW - nematodes KW - genomics KW - helminths KW - neglected diseases Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-210209 SN - 1664-8021 VL - 11 IS - 791 ER - TY - JOUR A1 - Augustin, Anne Marie A1 - Welsch, Stefan A1 - Bley, Thorsten Alexander A1 - Lopau, Kai A1 - Kickuth, Ralph T1 - Color-coded summation images in the evaluation of renal artery stenosis before and after percutaneous transluminal angioplasty JF - BMC Medical Imaging N2 - Background: Endovascular therapy is the gold standard in patients with hemodynamic relevant renal artery stenosis (RAS) resistant to medical therapy. The severity grading of the stenosis as well as the result assessment after endovascular approach is predominantly based on visible estimations of the anatomic appearance. We aim to investigate the application of color-coded DSA parameters to gain hemodynamic information during endovascular renal artery interventions and for the assessment of the procedures technical success. Methods: We retrospectively evaluated 32 patients who underwent endovascular renal artery revascularization and applied color-coded summation imaging on selected monochromatic DSA images. The differences in time to peak (dTTP) of contrast enhancement in predefined anatomical measuring points were analyzed. Furthermore, differences in systolic blood pressure values (SBP) and serum creatinine were obtained. The value of underlying diabetes mellitus as a predictor for clinical outcome was assessed. Correlation analysis between the patients gender as well as the presence of diabetes mellitus and dTTP was performed. Results: Endovascular revascularization resulted in statistically significant improvement in 4/7 regions of interest. Highly significant improvement of perfusion in terms of shortened TTP values could be found at the segmental artery level and in the intrastenotical segment (p<0.001), significant improvement prestenotical and in the apical renal parenchyma (p<0.05). In the other anatomic regions, differences revealed not to be significant. Differences between SBP and serum creatinine levels before and after the procedure were significant (p=0.004 and 0.0004). Patients ' gender as well as the presence of diabetes mellitus did not reveal to be predictors for the clinical success of the procedure. Furthermore, diabetes and gender did not show relevant correlation with dTTP in the parenchymal measuring points. Conclusions: The supplementary use of color-coding DSA and the data gained from parametric images may provide helpful information in the evaluation of the procedures ' technical success. The segmental artery might be a particularly suitable vascular territory for analyzing differences in blood flow characteristics. Further studies with larger cohorts are needed to further confirm the diagnostic value of this technique. KW - digital subtraction angiography KW - color-coded KW - endovascular KW - renal artery KW - PTA Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-259086 VL - 21 IS - 1 ER - TY - JOUR A1 - Stolze, Ina A1 - Trautmann, Axel A1 - Goebeler, Matthias A1 - Stoevesandt, Johanna T1 - Dangerous Leg Cramps: Severe Pustular Exanthema Caused by an Over-the-Counter Drug JF - Acta Dermato-Venereologica N2 - Abstract is missing KW - leg cramps KW - over-the-counter drugs KW - pustular exanthema KW - quinine KW - allergy Y1 - 2016 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-171285 VL - 96 ER - TY - INPR A1 - Händel, Barbara A1 - Schölvinck, Marieke T1 - The brain during free movement – what can we learn from the animal model T2 - Brain Research N2 - Animals, just like humans, can freely move. They do so for various important reasons, such as finding food and escaping predators. Observing these behaviors can inform us about the underlying cognitive processes. In addition, while humans can convey complicated information easily through speaking, animals need to move their bodies to communicate. This has prompted many creative solutions by animal neuroscientists to enable studying the brain during movement. In this review, we first summarize how animal researchers record from the brain while an animal is moving, by describing the most common neural recording techniques in animals and how they were adapted to record during movement. We further discuss the challenge of controlling or monitoring sensory input during free movement. However, not only is free movement a necessity to reflect the outcome of certain internal cognitive processes in animals, it is also a fascinating field of research since certain crucial behavioral patterns can only be observed and studied during free movement. Therefore, in a second part of the review, we focus on some key findings in animal research that specifically address the interaction between free movement and brain activity. First, focusing on walking as a fundamental form of free movement, we discuss how important such intentional movements are for understanding processes as diverse as spatial navigation, active sensing, and complex motor planning. Second, we propose the idea of regarding free movement as the expression of a behavioral state. This view can help to understand the general influence of movement on brain function. Together, the technological advancements towards recording from the brain during movement, and the scientific questions asked about the brain engaged in movement, make animal research highly valuable to research into the human “moving brain”. KW - free movement KW - animal research KW - virtual reality KW - recording methods KW - brain activity Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-251406 ET - accepted manuscript ER - TY - JOUR A1 - Kemmler, Wolfgang A1 - Kohl, Matthias A1 - Fröhlich, Michael A1 - Jakob, Franz A1 - Engelke, Klaus A1 - von Stengel, Simon A1 - Schoene, Daniel T1 - Effects of High‐Intensity Resistance Training on Osteopenia and Sarcopenia Parameters in Older Men with Osteosarcopenia—One‐Year Results of the Randomized Controlled Franconian Osteopenia and Sarcopenia Trial (FrOST) JF - Journal of Bone and Mineral Research N2 - Dynamic resistance exercise (DRT) might be the most promising agent for fighting sarcopenia in older people. However, the positive effect of DRT on osteopenia/osteoporosis in men has still to be confirmed. To evaluate the effect of low‐volume/high‐intensity (HIT)‐DRT on bone mineral density (BMD) and skeletal muscle mass index (SMI) in men with osteosarcopenia, we initiated the Franconian Osteopenia and Sarcopenia Trial (FrOST). Forty‐three sedentary community‐dwelling older men (aged 73 to 91 years) with osteopenia/osteoporosis and SMI‐based sarcopenia were randomly assigned to a HIT‐RT exercise group (EG; n = 21) or a control group (CG; n = 22). HIT‐RT provided a progressive, periodized single‐set DRT on machines with high intensity, effort, and velocity twice a week, while CG maintained their lifestyle. Both groups were adequately supplemented with whey protein, vitamin D, and calcium. Primary study endpoint was integral lumbar spine (LS) BMD as determined by quantitative computed tomography. Core secondary study endpoint was SMI as determined by dual‐energy X‐ray absorptiometry. Additional study endpoints were BMD at the total hip and maximum isokinetic hip−/leg‐extensor strength (leg press). After 12 months of exercise, LS‐BMD was maintained in the EG and decreased significantly in the CG, resulting in significant between‐group differences (p < 0.001; standardized mean difference [SMD] = 0.90). In parallel, SMI increased significantly in the EG and decreased significantly in the CG (p < 0.001; SMD = 1.95). Total hip BMD changes did not differ significantly between the groups (p = 0.064; SMD = 0.65), whereas changes in maximum hip−/leg‐extensor strength were much more prominent (p < 0.001; SMD = 1.92) in the EG. Considering dropout (n = 2), attendance rate (95%), and unintended side effects/injuries (n = 0), we believe our HIT‐RT protocol to be feasible, attractive, and safe. In summary, we conclude that our combined low‐threshold HIT‐RT/protein/vitamin D/calcium intervention was feasible, safe, and effective for tackling sarcopenia and osteopenia/osteoporosis in older men with osteosarcopenia. KW - exercise KW - osteoporosis KW - sarcopenia KW - aging KW - bone QCT Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-214609 VL - 35 IS - 9 SP - 1634 EP - 1644 ER - TY - THES A1 - Dahinten, Anna T1 - Baghdadit - Biozemente in der Anwendung als endodontischer Funktionswerkstoff T1 - Baghdadite - biocements in the application as endodontic functional material N2 - In kürzlich erschienenen Studien hat sich die Zementformulierung Baghdadit (Ca3ZrSi2O9) durch Eigenschaften wie eine hydraulische Aktivität, Röntgenopazität und bioaktive Wirkung als potenzielles Material für die endodontische Anwendung qualifiziert. Ziel dieser Studie war es, Baghdadit als einphasigen Biozement und in Form verschiedener Materialzusammensetzungen auf vorteilhafte Eigenschaften im Hinblick auf die Anwendung als endodontischen Funktionswerkstoff zu untersuchen. Nach eigenständiger Herstellung des mechanisch aktivierten Zementpulvers Ca3ZrSi2O9, erfolgte die Charakterisierung der verschiedenen Zementformulierungen maBag, Bag100Bru und Bag50Bru hinsichtlich der Injizierbarkeit, des pH-Verlaufs während der Abbindung, der Druckfestigkeit und Phasenzusammensetzung mittels XRD. Daneben wurde Baghdadit zu je drei verschiedenen Gewichtsanteilen als Füllstoff in eine Methacrylat-basierte Matrix integriert und hinsichtlich der Fließfähigkeit entsprechend der Norm DIN EN ISO 6876:2012, des qualitativen Polymerisationsgrads und der Druckfestigkeit geprüft. Mit einer Auswahl der oben genannten Materialien erfolgte die Untersuchung der antibakteriellen Wirksamkeit, der Röntgensichtbarkeit orientierend an der Norm DIN EN ISO 13116:2014 und der Dichtigkeit im Wurzelkanal. N2 - In recent studies, the cement formulation Baghdadite (Ca3ZrSi2O9) has been qualified as a potential material for endodontic application by properties such as a hydraulic activity, radiopacity and bioactive effect. The aim of this study was to investigate baghdadite as a single-phase biocement and in the form of different material compositions for advantageous properties with regard to its application as an endodontic filling material. After the production of the mechanically activated cement powder Ca3ZrSi2O9, the different cement formulations maBag, Bag100Bru and Bag50Bru were characterized with regard to injectability, pH curve during setting, compressive strength and phase composition carried out by XRD. In addition, baghdadite was integrated as filler into a methacrylate-based matrix in three different proportions by weight. These experimental sealers were tested with regard to flowability according to DIN EN ISO 6876:2012, the qualitative degree of polymerization and the compressive strength. With a selection of the above-mentioned materials the investigation of the antibacterial efficacy, the radiopacity based on the standard DIN EN ISO 13116:2014 and the sealing ability in bovine root canals were carried out. KW - Endodontie KW - Funktionswerkstoff KW - Baghdadit KW - Biozement KW - Zahnmedizin Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-319892 ER - TY - THES A1 - Lenard, Chris T1 - Ansätze zur informatik-gestützten Vorherbestimmung der Behandlungszeit anhand von Befundungsdaten bei Kontroll- und Schmerzfällen in der Zahnarztpraxis T1 - Approaches to Computer-Assisted Prediction of Treatment Time Based on Diagnostic Data for Control and Pain Cases in Dental Practice N2 - Diese retrospektive Studie untersuchte Patientenakten des elektronischen Karteikartensystems einer privaten Zahnarztpraxis von Patienten, welche zur Kontrolluntersuchung oder wegen Schmerzen vorstellig waren. Ziel der Studie war das Entwickeln von Methoden zur Vorhersage der Behandlungszeit für zukünftige Termine anhand verschiedener Patienteninformationen. Mittels statistischer deskriptiver Auswertung wurden die erfassten Daten untersucht und Korrelationen in Hinblick auf die Behandlungsdauer zwischen den verschiedenen Attributen hergestellt. Es wurden verschiedene Methoden zur Vorherbestimmung der Behandlungsdauer aufgestellt und auf ihr Optimierungspotential getestet. Die Methode mit dem höchsten Optimierungswert war ein Ansatz maschinellen Lernens. Der entworfene Algorithmus berechnete Behandlungszeiten der Testgruppe anhand eines Neuronalen Netzes, welches durch Trainieren mit den Daten der Untersuchungsgruppe erstellt wurde. N2 - his retrospective study examined patient records from the electronic medical record system of a private dental practice for patients who presented for routine check-ups or due to pain. The aim of the study was to develop methods for predicting treatment time for future appointments based on various patient information. Through statistical descriptive analysis, the collected data were examined, and correlations were established between different attributes in terms of treatment duration. Various methods for predicting treatment time were proposed and tested for their optimization potential. The method with the highest optimization value was a machine learning approach. The designed algorithm calculated treatment times for the test group using a neural network created by training with the data from the study group. KW - Maschinelles Lernen KW - Behandlungsdauer KW - Vorherbestimmung KW - Dental Practice KW - Treatment Time KW - Predicting KW - Zahnarztpraxis Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-320348 ER - TY - THES A1 - Müller, Annika Wiebke T1 - Funktionalität eines \(Stathmin\)-Promotor-Polymorphismus T1 - Functionality of a \(stathmin\) promoter polymorphism N2 - Bereits in vorausgegangenen Studien konnte nachgewiesen werden, dass das Stathmin-Gen eine entscheidende Rolle im Hinblick auf erlernte und angeborene Angstreaktionen spielt. So konnte Frau Dr. Julia Katharina Heupel in ihrer Arbeit aus dem Jahr 2013 eine Assoziation eines (TAA)n-Polymorphismus, welcher sich ca. 2 kb upstream des ersten Exons des Stathmin-Gens und ca. 4 kb upstream des Translationsstarts befindet, mit Cluster-C-Persönlichkeitsstörungen belegen. Sie vermutete, dass eine Hochregulation der Expression des Stathmin-Gens ein Risikofaktor für die Entstehung von Cluster C Persönlichkeitsstörungen darstellen könnte. Da sich der beschriebene Polymorphismus in der Promotor-Region des Stathmin-Gens befindet, ist eine allelspezifische Auswirkung auf die Genexpression vorstellbar. Um diese Vermutung zu stützen, wurde in dieser Arbeit die Auswirkung zweier Allele des STR-Polymorphismus im Bereich der Promotorregion des Stathmin-Gens im Hinblick auf die Promotoraktivität untersucht. Hierzu wurde die zu untersuchende Sequenz zunächst mittels Polymerase-Ketten-Reaktion vervielfältigt und anschließend in einen pGL4.23.Vektor kloniert. Im Anschluss daran erfolgte die Untersuchung der Promotoraktivität mittels eines Luciferase-Assays in der humanen Neuroblastomzelllinie SH-SY5Y. Nach statischer Auswertung der Messreihen zeigte sich eine signifikant höhere Luciferase-Aktivität des STR-Polymorphismus (TAA)12 im Vergleich zu dem STR-Polymorphismus (TAA)13. Hierdurch kann von einer höheren Promotoraktivität bei dem Genotyp (TAA)12 gegenüber dem Genotyp (TAA)13 ausgegangen werden. Zusammenfassend unterstützen die Ergebnisse dieser Arbeit die These, dass es sich bei dem Stathmin-Gen um ein Suszeptibilitätsgen für die Entstehung von Cluster C Persönlichkeitsstörungen handeln könnte. N2 - Previous studies have shown that the stathmin gene plays a crucial role in both learned and innate fear. In 2013 Dr. Julia Katharina Heupel suggested an association between a (TAA)n-polymorphism - which is located around 2 kb upstream of the first exon of the stathmin gene and around 4 kb upstream of the translation start site – with Cluster C personality disorders. She assumed that the upregulation of the stathmin gene expression constitutes a risk factor for the development of Cluster C personality disorders. Since the polymorphism described is located in the promoter region of the stathmin gene, an allele-specific effect on gene expression is conceivable. To support this premise, the impact on promoter activity of two alleles of the STR polymorphism located in the promoter region of the stathmin gene was investigated. First the sequence was amplified using polymerase chain reaction and then cloned into a pGL4.23 vector. Subsequently, the promoter activity was analyzed using a luciferase assay in the human neuroblastoma cell line SH-SY5Y. After statistical evaluation a significantly higher luciferase activity of the STR polymorphism (TAA)12 was shown in comparison to the STR polymorphism (TAA)13. As a result, it can be assumed that the genotype (TAA)12 has a higher promoter activity than the genotype (TAA)13. In summary, the results of this work support the thesis that the stathmin gene could be a susceptibility gene for the development of Cluster C personality disorders. KW - Persönlichkeitsstörung KW - Stathmin KW - Cluster C Persönlichkeitsstörungen KW - Promotorpolymorphismus KW - Cluster C personality disorders KW - promoter polymorphism Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-318120 ER - TY - THES A1 - Ranecky, Maria Helena T1 - Experimentelle Charakterisierung intestinaler, GvHD-protektiver myeloider Empfängerzellen nach allogener Stammzelltransplantation T1 - Experimental Characterization of Intestinal GvHD-Protective Myeloid Host Cells after Allogeneic Stem Cell Transplantation N2 - Die akute Graft-versus-Host Disease (GvHD) und speziell ihre intestinale Manifestation ist eine schwere Komplikation der allogenen Stammzelltransplantation mit erheblichem Einfluss auf Mortalität und Morbidität der Patienten. Pathophysiologisch stellt sie eine Immunreaktion von Spender-T-Zellen auf Empfängergewebestrukturen dar. In Versuchsmäusen ist die experimentelle Depletion CD11c+ Antigen-präsentierender Empfängerzellen in der frühen GvHD-Effektorphase assoziiert mit einem schlechteren klinischen Outcome, einer höheren Dichte alloreaktiver T-Zellen und einer verstärkten Entzündungsreaktion in der intestinalen Mukosa. Ziel der Studie war eine umfassende Charakterisierung und systematische Einordnung der folglich GvHD-protektiven intestinalen CD11c+ Empfängerzellen. Bezüglich ihrer Oberflächenproteinsignatur analysierten wir die myeloiden Zellen der intestinalen Mukosa am Tag 6 nach allogener Stammzelltransplantation. Mittels durchflusszytometrischer Analyse und Vergleich zwischen gesunden, allein bestrahlten und GvHD-Mäusen ordneten wir die CD11c+ Empfängerzellen als Makrophagen ein und schlossen eine Identität als dendritische Zellen aus. In der Immunfluoreszenzmikroskopie wiesen wir ihre Kolokalisation mit allogenen T-Zellen nach und bestätigten darin eine PD-L1 Expression als möglichen T-Zell-Suppressionsmechanismus. Bezüglich ihres Transkriptoms führten wir eine Einzelzell-RNA-Sequenzierung intestinaler hämatopoetischer Empfängerzellen aus CD11c+ Zell-depletierten und nicht depletierten Mäusen durch. Auf rein bioinformatischer Grundlage wurden die Einzelzellen kombiniert und anhand ihrer Transkriptomprofile in Cluster eingeteilt. Der Vergleich beider Versuchsgruppen offenbarte zwei unterschiedliche präsente bzw. depletierte und damit GvHD-protektive Zellcluster: Cluster 4 enthielt Zellen mit deutlicher Makrophagensignatur und gewebeprotektivem, antipathogenem Effektorprofil, welches in Kombination mit weiteren Genen ein Kontinuum der in Homöostase vorhandenen Makrophagen nahelegte. Cluster 10 dagegen enthielt Zellen mit immun- und spezifisch T-Zell-suppressivem Effektorprofil, weniger deutlicher Makrophagensignatur und Ähnlichkeit zu myeloiden Suppressorzellen. Somit lieferte die Studie wichtige Hinweise auf einen Mechanismus der GvHD- bzw. T-Zell-Suppression und Gewebeprotektion in Form von physiologisch vorhandenen bzw. im Laufe der GvHD auftretenden Empfängermakrophagen. N2 - Acute Graft-versus-host disease (GvHD) is an immunoreaction of donor T cells against host tissue structures after allogeneic hematopoietic cell transplantation (allo-HCT). Especially intestinal GvHD greatly contributes to the patients´ morbidity and mortality. Experimental depletion of CD11c+ antigen-presenting host cells in the early effector phase of GvHD is associated with a worse clinical outcome, an increase of alloreactive T cell numbers and more severe inflammation in the small intestinal mucosa in mice. In this study we aimed to characterize and systematically classify intestinal CD11c+ host cell populations protecting from acute GvHD on proteome and transcriptome level. To address the protein expression signature we analyzed the surface antigens of intestinal CD11c+ antigen-presenting cells of host mice on day 6 after allo-HCT. By flow cytometric analysis and comparison of healthy, GvHD-, and mice only receiving myeloablative irradiation, we classified the GvHD-protective cells as macrophages and ruled out a dendritic cell identity. Utilizing immunofluorescence microscopy we localized intestinal host macrophages in close contact with allogeneic T cells and confirmed their expression of PD-L1 as possible mechanism of alloreactive T cell suppression. Concerning the transcriptome signature, we performed a single-cell RNA sequencing of host intestinal hematopoietic cells of GvHD-mice with and without CD11c+ cell depletion. Single cells were combined and clustered by transcriptional profiling based on bioinformatic calculation. In comparison of both groups we detected two different present, respectively depleted and hence GvHD-protective cell populations: Cluster 4 containing tissue-protective and antipathogenic cells with a distinct macrophage signature, suggesting a continuum of steady state’s macrophages. And Cluster 10 containing cells with highly immunomodulatory and T cell suppressive capacities, less distinct macrophage signature, and some similar features to myeloid-derived suppressor cells. This study details the characteristics of host intestinal macrophages that can regulate alloreactive T cells in the small intestinal mucosa, suppress lethal acute GvHD and protect the tissue from inflammatory destruction. KW - Makrophage KW - Dünndarm KW - PD-L1 KW - Single-cell RNA Sequencing KW - Graft-versus-host disease (GvHD) Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-310924 ER - TY - THES A1 - Heinemann, Hannes T1 - Lebensqualität und Coping beim Multiplen Myelom T1 - Quality of Life and Coping with Multiple Myeloma N2 - Einführung: Beim Multiplen Myleom handelt es sich um eine bösartige Proliferation der Plasmazellen, wenn es auch nur 1% aller bösartigen Erkrankungen ausmacht, muss angesichts der steigenden Lebenserwartung von einer Zunahme der Fälle ausgegangen werden. Methoden: Diese Dissertation soll als Übersichtsarbeit zur QoL und Coping bei MM-Patienten und deren Angehörigen dienen. Es konnten 101 relevante Studien in der Literaturrecherche gefunden werden. Resultate: In allen Bereichen lag bei MM-Patienten, abgesehen von frühen Stadien oder bei Patienten mit CR, eine schlechtere QoL als bei der Referenzpopulation vor. Diese Ergebnisse waren unabhängig vom verwendeten QoL-Erhebungsinstrument. Vor allem die Tatsache, dass Multiples Myleom unheilbar ist, ist für die Patienten sehr belastend. Es lagen die unterschiedlichsten Coping-Mechanismen bei den Patienten und deren Angehörigen vor. Soziale Unterstützung war meistens der QoL förderlich, wenn es auch problematische Formen gab. Es konnten diverse, teils widersprüchliche Korrelationen von QoL und demographischen Faktoren, wie Alter und Geschlecht gefunden werden. Diskussion: Auch wenn in den letzten Jahren vermehrt in diesem Gebiet geforscht wurde, gestaltete es sich als schwierig Studien zu dem Thema zu finden und es bleibt zu hoffen, dass zukünftig ein größerer Fokus hier gelegt wird. N2 - Introduction: Multiple myeloma (MM) is a malignant proliferation of plasma cells, although it accounts for only 1% of all malignancies, with increasing life expectancy the number of cases is expected to increase. Methods: This dissertation is intended to serve as a review of quality of life (QoL) and coping in MM patients and their families. In the search in pubmed 101 relevant studies could be found. Results: In all areas, apart from early stages or patients with complete response, MM patients had a poorer QoL than the reference population. These results were independent of the QoL survey instrument used. Above all, the fact that MM is incurable is very stressful for patients. There were different coping mechanisms of the patients and their relatives. Social support was mostly conducive to QoL, although there were problematic forms. Various, sometimes contradictory correlations of QoL and demographic factors such as age and gender were found. Discussion: Even though in recent years there has been increased research in this area, it has proved difficult to find studies on the subject and it is to be hoped that there will be a greater focus here in the future. KW - Plasmozytom KW - QoL KW - Multiple Myeloma KW - review KW - coping KW - symptoms Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-313227 ER - TY - THES A1 - Heinemann, Jonas T1 - Evaluation der aktuellen Therapie von Bandverletzungen am oberen Sprunggelenk T1 - Evaluation of the current therapy of ligament injuries of the upper ankle joint N2 - Die fibulare Kapselbandverletzung ist eine der häufigsten Verletzungen im Alltag und im Sport. Durch das hohe Patientenaufkommen mit finanziellen Auswirkungen entsteht eine Belastung für das Gesundheitssystem. Nicht selten wird die Verletzung bagatellisiert und endet in chronischen Folgen. Zur Erhebung der bis dato unklaren Versorgungsrealität führten wir eine Onlinebefragung durch. Kernfrage war, ob Einheitlichkeit in der Therapie der fibularen Kapselbandverletzung herrscht. Leitende Ärzte orthopädischer/ unfallchirurgischer Kliniken sowie GFFC-Mitglieder wurden online mittels standardisierten Fragebogens gebeten, an einer Befragung teilzunehmen. Untersuchte Faktoren waren Einsatz von Bildgebung, Ottawa Ankle Rules, Immobilisation, Belastung, Rehabilitationsmaßnahmen, OP-Indikationen, operative Techniken und generelle Handlungsleitlinien. Insgesamt 549 vollständig ausgefüllte Fragebögen wurden analysiert. Die Rückantwortquote lag bei 24,69 %. Gefragt nach der Diagnostik und Therapie unterscheiden sich die Antworten vermehrt in Abhängigkeit des jeweiligen Versorgungsstatus. Im Mittel wird die niedriggradige Verletzung mit einer Orthese oder einem Tape-/ Stützverband ruhiggestellt, die höhergradige anfangs auch mit einem Gips und im Verlauf mit einer Orthese. Drittgradig Verletzte erhalten unterstützend Unterarmgehstützen. Operiert wird bei der primären Verletzung selten. Im Falle einer OP wird in 72,5 % der Fälle arthroskopisch vorgegangen. Anhand unserer Ergebnisse wird deutlich, dass es eine grobe Behandlungspräferenz gibt: die konservative, frühfunktionelle Therapie mit einer Orthesenversorgung für vier bis sechs Wochen. Jedoch kann man von keiner Einheitlichkeit sprechen, da sich bei Teilaspekten derselben Verletzungsschwere unterschiedliche, teils widersprüchliche Behandlungspfade ergaben. Häufig unterschieden sich die Versorgungsstufen in ihrem Vorgehen. Als Problem sehen wir die fehlende Kenntnis, der zu dem Krankheitsbild gehörenden Leitlinie. Weitere Aufmerksamkeit und Aufklärung sind vonnöten. N2 - Fibular capsular ligament injury is one of the most common injuries in everyday life and in sports. The high volume of patients creates a burden with financial implications for the healthcare system. It is not uncommon for the injury to be trivialized which can cause chronic consequences. We conducted an online survey to investigate the hitherto unclear reality of care. The key question was whether there is a uniformity in the treatment of fibular capsular ligament injuries. Leading physicians of orthopedic/trauma surgery clinics and GFFC members were asked to participate in an online survey using a standardized questionnaire. Factors examined were use of imaging, Ottawa Ankle Rules, immobilization, weight bearing, rehabilitation measures, surgical indications, surgical techniques and general guidelines for action. A total of 549 completed questionnaires were analyzed. The response rate was 24.69%. When asked about diagnostics and therapy, the answers differed increasingly depending on the respective care status. On average, the low-grade injurie is immobilized with an orthosis or a tape/support bandage, the higher-grade injury is initially immobilized with a cast and later with an orthosis. Third-degree injuried patients receive supportive crutches. Surgery is rarely performed for primary injuries. In the case of surgery, arthroscopic surgery is performed in 72.5% of cases. Based on our results it becomes clear that there is a rough treatment preference: conservative, early functional therapy with an orthosis for four to six weeks. However, it is not possible to speak of uniformity, because for the same severity of injury, there are different, sometimes contradictory treatment paths for certain aspects. The care levels often differed in their approach. We see a problem in the lack of knowledge of the guideline. Further attention and education are needed. KW - Oberes Sprunggelenk KW - Sprunggelenk Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-313189 ER - TY - THES A1 - Taleh, Scharoch T1 - Einfluss kardiovaskulärer Risikofaktoren und Komorbiditäten auf die Progression einer mittelgradigen und hochgradigen Aortenklappenstenose T1 - Association between comorbidities and progression of transvalvular pressure gradients in patients with moderate and severe aortic valve stenosis N2 - Bei dieser retrospektiven monozentrischen Studie wurden insgesamt 402 Patienten (mittleres Alter 78 ± 9,4 Jahre, 58 % männlich) eingeschlossen. Zwischen April 2006 und Februar 2016 erfolgten zwei aufeinanderfolgende TTE im Abstand von mindestens einem Jahr; berücksichtigt wurden alle Patienten mit mindestens der Diagnose einer mittelgradigen AS zum Follow-up-Zeitpunkt. Laborparameter, Medikationen und das Auftreten von acht kardialen Komorbiditäten und Risikofaktoren (aHT, DM, KHK, pAVK, CKD, cerebrovaskuläre Erkrankungen, BMI ≥ 30 kg/m² und Nikotinabusus) wurden hierzu analysiert. Es folgte eine Unterteilung der Patienten in zwei Gruppen, eine mit langsamer Progression (AV-Pmean < 5 mmHg/Jahr) und eine mit schneller Progression (AV-Pmean ≥ 5 mmHg/Jahr). Die durchschnittliche Follow-up-Dauer betrug 3,4 ± 1,9 Jahre. Die Patienten hatten im Durchschnitt 3,1 ± 1,6 kardiale Komorbiditäten und Risikofaktoren. Die Anzahl der Faktoren zeigte sich in der Gruppe der langsamen Progression erhöht (Anzahl kardialer Komorbiditäten und Risikofaktoren langsame Progressionsgruppe vs. schnelle Progressionsgruppe: 3,3 ± 1,5 vs. 2,9 ± 1,7; P = 0,036). Die Ergebnisse der vorliegenden Arbeit veranschaulichen, dass Patienten mit moderater oder schwerer AS und einer hohen Prävalenz von kardialen Komorbiditäten und Risikofaktoren, vor allem nach Myokardinfarkt, KHK und DM, generell eine langsamere Progression des Pmean über der AV zeigen im Vergleich zu Patienten mit einer geringen Prävalenz von kardialen Komorbiditäten und Risikofaktoren. Eine höhere LDL-C-Konzentration im Blut ist ein Risikofaktor für eine schnelle AV-Pmean-Progression, während eine höhere CRP-Konzentration verbunden ist mit einer langsameren AV-Pmean-Progression. Dies zeigt eine starke Korrelation zwischen der Prävalenz von kardialen Komorbiditäten und Inflammationsstress. Unter der Annahme einer klinischen Anwendbarkeit der Ergebnisse dieser Arbeit lassen sich Patienten mit bekannter AS, die ein erhöhtes Risiko für einen schnellen Progress der Stenose haben, besser identifizieren und herausfiltern und somit engmaschiger kontrollieren und auch frühzeitiger behandeln. Dieser mögliche Zeitvorteil ist von großer Bedeutung aufgrund der geringen Überlebensrate bei hochgradiger AS und der nachweislichen Reduktion von Mortalität und Morbidität bei frühzeitiger Überweisung in spezialisierte Zentren N2 - Fast progression of the trans-aortic mean gradient (Pmean) is relevant for clinical decision making of valve replacement in patients with moderate and severe aortic stenosis (AS) patients. However, there is currently little knowledge regarding the determinants affecting progression of transvalvular gradient in AS patients. This monocentric retrospective study included consecutive patients presenting with at least two transthoracic echocardiography examinations covering a time interval of one year or more between April 2006 and February 2016 and diagnosed as moderate or severe aortic stenosis at the final echocardiographic examination. Laboratory parameters, medication, and prevalence of eight known cardiac comorbidities and risk factors (hypertension, diabetes, coronary heart disease, peripheral artery occlusive disease, cerebrovascular disease, renal dysfunction, body mass index ≥30Kg/m², and history of smoking) were analyzed. Patients were divided into slow (Pmean<5mmHg/year) or fast (Pmean≥5mmHg/year) progression groups. A total of 402 patients (mean age 78±9.4 years, 58% males) were included in the study. Mean follow-up duration was 3.4±1.9 years. The average number of cardiac comorbidities and risk factors was 3.1±1.6. Average number of cardiac comorbidities and risk factors was higher in patients in slow progression group than in fast progression group (3.3±1.5 vs 2.9±1.7; P=0.036). Patients in slow progression group had more often coronary heart disease (49.2% vs 33.6%; P=0.003) compared to patients in fast progression group. LDL-cholesterol values were lower in the slow progression group (100±32.6mg/dl vs 110.8±36.6mg/dl; P=0.005). These findings suggest that disease progression of aortic valve stenosis is faster in patients with fewer cardiac comorbidities and risk factors, especially if they do not have coronary heart disease. Further prospective studies are warranted to investigate the outcome of patients with slow versus fast progression of transvalvular gradient with regards to comorbidities and risk factors. KW - Aortenstenose KW - Aortenklappenersatz KW - Koronare Herzkrankheit KW - Kardiovaskuläre Krankheit KW - Transthorakale Echokardiographie KW - Aortenklappenstenose KW - mittlerer transvalvulärer Druckgradient KW - Kardiovaskuläre Risikofaktoren KW - Aortic valve replacement KW - Aortic valve stenosis KW - transthoracic echocardiography Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-313401 ER - TY - JOUR A1 - Peterka, Manuel A1 - Odorfer, Thorsten A1 - Schwab, Michael A1 - Volkmann, Jens A1 - Zeller, Daniel T1 - LSVT-BIG therapy in Parkinson's disease: physiological evidence for proprioceptive recalibration JF - BMC Neurology N2 - Background There is growing evidence for proprioceptive dysfunction in patients with Parkinson's disease (PD). The Lee Silvermann Voice Treatment-BIG therapy (LSVT-BIG), a special training program aiming at an increase of movement amplitudes in persons with PD (PwPD), has shown to be effective on motor symptoms. LSVT-BIG is conceptionally based on improving bradykinesia, in particular the decrement of repetitive movements, by proprioceptive recalibration. Objective To assess proprioceptive impairment in PwPD as compared to matched controls and to probe potential recalibration effects of the LSVT-BIG therapy on proprioception. Methods Proprioceptive performance and fine motor skills were assessed in 30 PwPD and 15 matched controls. Measurements with significant impairment in PwPD were chosen as outcome parameters for a standardized 4 weeks amplitude-based training intervention (LSVT-BIG) in 11 PwPD. Proprioceptive performance served as primary outcome measure. Secondary outcome measures included the motor part of the MDS-UPDRS, the nine-hole-peg test, and a questionnaire on quality of life. Post-interventional assessments were conducted at weeks 4 and 8. Results Compared to the control group, PwPD showed significantly larger pointing errors. After 4 weeks of LSVT-BIG therapy and even more so after an additional 4 weeks of continued training, proprioceptive performance improved significantly. In addition, quality of life improved as indicated by a questionnaire. Conclusion LSVT-BIG training may achieve a recalibration of proprioceptive processing in PwPD. Our data indicates a probable physiological mechanism of a symptom-specific, amplitude-based behavioral intervention in PwPD. KW - Proprioception KW - Amplitude KW - Training KW - Pointing error KW - LSVT-big therapy Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-230084 VL - 20 ER - TY - JOUR A1 - Heinz, Tizian A1 - Meller, Felix A1 - Luetkens, Karsten Sebastian A1 - Horas, Konstantin A1 - Schäfer, Thomas A1 - Rudert, Maximilian A1 - Reppenhagen, Stephan A1 - Weißenberger, Manuel T1 - Can the MRI based AMADEUS score accurately assess pre-surgery chondral defect severity according to the ICRS arthroscopic classification system? JF - Journal of Experimental Orthopaedics N2 - Purpose The AMADEUS (Area Measurement And DEpth and Underlying Structures) scoring and grading system has been proposed for the MRI based evaluation of untreated focal chondral defects around the knee. The clinical practicability, its correlation with arthroscopically assessed grading systems (ICRS – International Cartilage Repair Society) and thereby its clinical value in terms of decision making and guiding prognosis was yet to determine. Methods From 2008 to 2019 a total of 89 individuals were indicated for high tibial valgus osteotomy (HTO) due to tibial varus deformity and concomitant chondral defects of the medial compartment of the knee. All patients received a preoperative MRI (1.5 Tesla or 3.0 Tesla) and pre-osteotomy diagnostic arthroscopy. Chondral defects of the medial compartment were scored and graded with the MRI based AMADEUS by three independent raters and compared to arthroscopic defect grading by the ICRS system. Interrater and intrarater reliability as well as correlation analysis with the ICRS classification system were assessed. Results Intraclass correlation coefficients for the various subscores of the AMADEUS showed an overall good to excellent interrater agreement (min: 0.26, max: 0.80). Intrarater agreement turned out to be substantially inferior (min: 0.08, max: 0.53). Spearman correlation revealed an overall moderate correlative association of the AMADEUS subscores with the ICRS classification system, apart from the defect area subscore. Sensitivity of the AMADEUS to accurately identify defect severity according to the ICRS was 0.7 (0.69 for 3.0 Tesla MRI, 0.67 for 1.5 Tesla MRI). The mean AMADEUS grade was 2.60 ± 0.81 and the mean ICRS score 2.90 ± 0.63. Conclusions Overall, the AMADEUS with all its subscores shows moderate correlation with the arthroscopic chondral grading system according to ICRS. This suggests that chondral defect grading by means of the MRI based AMADEUS is well capable of influencing and guiding treatment decisions. Interrater reliability shows overall good agreement. KW - MRI KW - knee KW - cartilage defect KW - grading system of chondral defects KW - AMADEUS KW - ICRS Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-300781 SN - 2197-1153 VL - 9 IS - 1 ER - TY - THES A1 - Stößel, Anna T1 - Auswirkungen zerebellärer Gleichstromstimulation auf das motorische Lernen bei gesunden älteren Probanden T1 - Effects of cerebellar anodal transcranial direct current stimulation on motor learning in healthy older adults N2 - Sowohl neurologische Erkrankungen als auch der natürliche Alterungsprozess gehen regelhaft mit einem Untergang von Neuronen einher und bedingen neurologische Funktionsverluste. Diese mit Hilfe nicht-invasiver Techniken, beispielsweise tDCS, zu reduzieren, stellt ein wichtiges Ziel der neurowissenschaftlichen Forschung dar. Neben Arbeiten, die tDCS-Effekte auf das motorische Lernen bei Stimulation des motorischen Kortex nachweisen konnten, gibt es auch Hinweise für solche Effekte bei Stimulation des Kleinhirns. Allerdings besteht derzeit noch eine hohe Variabilität und damit einhergehend eine schlechte Vergleichbarkeit der Studien bezüglich ihrer Stimulationsbedingungen. Das Ansprechen unterschiedlicher Altersgruppen bleibt unklar. In der vorliegenden Arbeit wurden die Effekte zerebellärer a-tDCS auf das motorische Lernen bei gesunden älteren Probanden untersucht. Im Cross-over-Design wurde zu unterschiedlichen Zeitpunkten (vor bzw. nach der motorischen Aufgabe) stimuliert und im 24-Stunden-Verlauf die Langzeitwirkung evaluiert. Gruppe A erhielt vor einer motorischen Übungsaufgabe eine zerebelläre Stimulation, entweder als a-tDCS oder Scheinstimulation, Gruppe B nach der Übungsaufgabe. Zur Überprüfung der Effekte auf das Sequenzlernen diente der Finger-Tapping-Task. Der Lernerfolg wurde anhand der Genauigkeit, der Sequenzdauer und des Skill-Index gemessen. Die Ergebnisse deuten darauf hin, dass eine zerebelläre a-tDCS vor einer Übungsaufgabe zu einer Verbesserung der Konsolidierung der Fähigkeit, eine Zahlenfolge möglichst schnell und gleichzeitig genau einzutippen, führt, während die Stimulation nach einer Übungsaufgabe das motorische Lernen nicht zu beeinflussen scheint. Insgesamt stützen die Ergebnisse zum Teil die bisherigen Hinweise, dass eine zerebellär applizierte a-tDCS das motorische Lernen verbessern kann. Aufgrund einiger Limitationen, besonders der geringen Gruppengröße, verbleibt dieses Ergebnis jedoch vorläufig und bedarf einer Bestätigung in größeren Probandengruppen. Es bleibt von hohem Interesse, die optimalen Bedingungen für die Anwendung von tDCS am Kleinhirn zu definieren, um motorische Lernprozesse positiv zu beeinflussen. Dies ist die Voraussetzung dafür, zerebelläre tDCS mittelfristig auch zu therapeutischen Zwecken anwenden zu können. N2 - Neurological diseases as well as the natural aging process are regularly accompanied by a loss of neurons resulting into a loss of neurological function. Reducing these impactswith the help of non-invasive techniques, such as transcranial direct current stiumulation (tDCS), is an important goal of neuroscientific research. In addition to studies successfully providing evidence that tDCS is impacting motor learning when stimulating the motor cortex, indication of similar effects exist when stimulating the cerebellum. Unfortunately studies today only provide poor comparability given the underlying inconsistency in stimulation conditions and consequentially yielded results. The response of different age groups remains unclear. The following study explores the effects of cerebellar anodal transranial direct current simulation (a-tDSC) on healthy elderly subjects. Using a crossover design, patience were stimulated at different times (before or after the motor task) and long-term effects were evaluated over a 24-hour period. Group A received cerebellar stimulation prior to a motor exercise in form of an actual a-tDCS or sham stimulation, Group B received treatment after the exercise. The finger tapping task was used to verify the effects on sequence learning. Learning success was measured by accuracy, sequence duration, and skill index. The results indicate that cerebellar a-tDCS prior to the exercise task leads to enhanced consolidation of the ability to type a sequence of numbers quickly and accurately at the same time, whereas stimulation after the exercise task does not seem to affect motor learning. Overall, the results partially support previous evidence that cerebellar applied a-tDCS can improve motor learning. Due to some limitations, in particular the small sample size, results are preliminary and require confirmation across a larger population. Defining the optimal conditions for the application of tDCS to the cerebellum to positively influence motor learning processes remains of high interest. It is the prerequisite to enable application of cerebellar tDCS for therapeutic purposes in the medium term. KW - Motorisches Lernen KW - Kleinhirn KW - transkranielle Gleichstromstimulation (tDCS) KW - finger-tapping task (FTT) KW - zerebelläre Gleichstromstimulation KW - motor learning KW - tDCS Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-317930 ER - TY - THES A1 - Ebner, Sebastian Manfred T1 - Antimykotikaresistenzen bei deutschen \(Candida\) \(auris\) Isolaten T1 - Antimycotic resistance in German \(Candida\) \(auris\) isolates N2 - Bei dem 2009 erstbeschriebenen Hefepilz C. auris handelt es sich um einen Keim, welcher aufgrund von nosokomialen Ausbrüchen und hohen Antimykotikaresistenzen Aufmerksamkeit erregte. Ziel dieser Arbeit war es in Deutschland gesammelte Isolate bezüglich vorhandener Resistenzen und Mutationen in Resistenzregionen zu testen und das epidemiologische Geschehen hierzulande mit dem globalen Auftreten des Keims zu vergleichen. Bezüglich der durchgeführten Resistenztestungen wiesen die CLSI-konformen Testarten (YO-Platten und E-Test-Verfahren) meist vergleichbare Ergebnisse auf. Für das EUCAST-konforme Mikrodilutionstestverfahren kann aufgrund eines stark ausgeprägten paradoxen Wachstumseffekts nur Anidulafungin, nicht jedoch Caspofungin, zur Testung empfohlen werden. Insgesamt erwiesen sich 25 % der Isolate als Caspofungin-resistent. Zwei Isolate zeigten eine Resistenz gegenüber allen getesteten Echinocandinen (16,7 %). Die höchsten Resistenzraten wurden gegenüber Fluconazol (92 %) beobachtet. Zwei der Isolate zeigten sich gegenüber Voriconazol resistent (16,7 %). Für Amphotericin B konnte eine Resistenzrate von 33,3 % festgestellt werden. Für die Wirkstoffe Posaconazol und Itraconazol erwiesen sich alle untersuchten Isolate als sensitiv. Dies konnte auch mit Ausnahme eines Isolates für 5-Flucytosin beobachtet werden. Die durch eine Sanger-Sequenzierung erhaltenen Sequenzen der Gene FKS1 und ERG11 wurden auf Mutationen untersucht, welche zu Aminosäuresubstitutionen im Gesamtprotein führten. Hierbei ergaben sich für zwei Isolate (16,7 %) Mutationen im FKS1-Hot Spot 1 (Typ S639F und S639Y). Beide Isolate zeigten sich in den AFST Echinocandin-resistent. Bei allen untersuchten Isolaten lagen Mutationen im ERG11 Gen vor. So fand sich in 8 Fällen eine Mutation des Typen Y132F (66,7 %), in 3 Fällen der Typ K143R (25 %) und in einem Fall der Typ F126L (8,3 %). Im Rahmen eines anderen Projekts wurde mit den hier gewonnenen PCR-Produkten ein WGS durchgeführt, um die Isolate durch SNPs-Vergleich mit Referenzstämmen phylogenetischen Clades zuzuordnen. Dabei konnten 91,7 % der Isolate dem südasiatischen Clade I und ein Isolat dem südafrikanischen Clade III zugeordnet werden. Aufgrund der geringen epidemiologischen Fallzahlen in Deutschland scheint gegenwärtig keine Bedrohung von C. auris auszugehen. Berichte aus anderen Ländern konnten allerdings eine rasche, ausbruchartige Zunahme von C. auris Fällen nachweisen. So kann nur angeraten werden das infektiologische Geschehen in Deutschland weiterhin zu beobachten. N2 - The fungus C. auris was first described in the year 2009. Because of a high number of nosocomial outbrakes and high antimycotic resistance rates the fungus attracted great media attention. The aim of this dissertion was to test German isolates for antimycotic resistance and mutations in resistance genes. Additionally, the epidemiological occurrence in Germany was compared to the global outspread. In this context CLSI-conform methods for resistance testing (YO-Plates and E-Test-Plates) generated comparable results. The testing of EUCAST-conform microdilution plates showed a strong paradoxical growth for Caspofungin. Because of this only Anidulafungin can be recommended for testing. In summary 25 % of the isolates were resistant against Caspofungin. Two isolates showed resistance against all tested Echinocandines (16,7 %). The highest rates were detected for Fluconazol (92 %). Furthermore, two of the isolates (16,7 %) showed resistance against Voriconazol. There was a resistance rate of 33,3 % to Amphotericin B. No isolate showed resistance against Posaconazol or Itraconazol. And only one isolate was resistant against 5-Flucytosin. Sanger-Sequencing was used to detect mutations in resistance genes FKS1 und ERG11, which could lead to a substitution of amino acids in the protein. There were two isolates (16,7 %) with mutations in FKS1-Hot Spot 1 (type S639F and S639Y). Both isolates showed a Echinocandin resistance in AFST. All tested isolates showed a mutation in ERG11. There were eight cases of type Y132F (66,7 %), three cases of K143R (25 %) and in one case type F126L (8,3 %). The PCR products of this study were used in a different project for WSG. This made it possible to group the isolates into phylogenetic clades. In summary 91,7 % of the isolates were related to Clade I (South Asia) and one isolate was related to Clade III (South Africa). Because of low epidemiologic occurence in Germany, there is little threat of servere health care issues at the moment. Reports from diffferent countries all over the world however, showed a quick, outbrake-like increase of C. auris cases. Therefore, further observation of German epidemiology is highly recommended. KW - Candida KW - Resistenz KW - Wirkstoff KW - Behandlung KW - Antimykotikaresistenz KW - Candida auris KW - Resistance mechanism C. auris KW - Mutation FKS Hot Spot 1/ERG11 KW - Nosokomiale Infektion KW - E-Test KW - Mikrodilutionstest KW - Hospitalismus KW - Pilz Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-318068 ER - TY - THES A1 - Rizzo, Giuseppe T1 - Determinants of macrophage and neutrophil heterogeneity in cardiac repair after myocardial infarction T1 - Determinante der Makrophagen- und Neutrophilien-Heterogenität bei der Herzreparatur nach Myokardinfarkt N2 - Current therapeutic strategies efficiently improve survival in patients after myocardial infarction (MI). Nevertheless, long-term consequences such as heart failure development, are still one of the leading causes of death worldwide. Inflammation is critically involved in the cardiac healing process after MI and has a dual role, contributing to both tissue healing and tissue damage. In the last decade, a lot of attention was given to targeting inflammation as a potential therapeutic approach in MI, but the poor understanding of inflammatory cell heterogeneity and function is a limit to the development of immune modulatory strategies. The recent development of tools to profile immune cells with high resolution has provided a unique opportunity to better understand immune cell heterogeneity and dynamics in the ischemic heart. In this thesis, we employed single-cell RNA-sequencing combined with detection of epitopes by sequencing (CITE-seq) to refine our understanding of neutrophils and monocytes/macrophages heterogeneity and dynamic after experimental myocardial infarction. Neutrophils rapidly invade the infarcted heart shortly after ischemic damage and have previously been proposed to display time-dependent functional heterogeneity. At the single-cell level, we observed dynamic transcriptional heterogeneity in neutrophil populations during the acute post-MI phase and defined previously unknown cardiac neutrophil states. In particular, we identified a locally acquired SiglecFhi neutrophil state that displayed higher ROS production and phagocytic ability compared to newly recruited neutrophils, suggesting the acquisition of specific function in the infarcted heart. These findings highlight the importance of the tissue microenvironment in shaping neutrophil response. From the macrophage perspective, we characterized MI-associated monocyte-derived macrophage subsets, two with a pro-inflammatory gene signature (MHCIIhiIl1βhi) and three Trem2hi macrophage populations with a lipid associated macrophage (LAM) signature, also expressing pro-fibrotic and tissue repair genes. Combined analysis of blood monocytes and cardiac monocyte/macrophages indicated that the Trem2hi LAM signature is acquired in the infarcted heart. We furthermore characterized the role of TREM2, a surface protein expressed mainly in macrophages and involved in macrophage survival and function, in the post-MI macrophage response and cardiac repair. Using TREM2 deficient mice, we demonstrate that acquisition of the LAM signature in cardiac macrophages after MI is partially dependent on TREM2. While their cardiac function was not affected, TREM2 deficient mice showed reduced collagen deposition in the heart after MI. Thus, our data in Trem2-deficient mice highlight the role of TREM2 in promoting a macrophage pro-fibrotic phenotype, in line with the pro-fibrotic/tissue repair gene signature of the Trem2hi LAM-signature genes. Overall, our data provide a high-resolution characterization of neutrophils and macrophage heterogeneity and dynamics in the ischemic heart and can be used as a valuable resource to investigate how these cells modulate the healing processes after MI. Furthermore, our work identified TREM2 as a regulator of macrophage phenotype in the infarcted heart N2 - Die derzeitigen therapeutischen Ansätze verbessern die Überlebenschancen von Patienten nach einem Myokardinfarkt wirksam, dennoch sind Langzeitfolgen wie die Entwicklung einer Herzinsuffizienz immer noch eine der häufigsten Todesursachen weltweit. An den Heilungsprozessen nach einem Herzinfarkt sind Entzündungreaktionen beteiligt, die sowohl zur Gewebeheilung als auch zur Gewebeschädigung beitragen. In den letzten zehn Jahren wurde besondere Aufmerksamkeit auf die gezielte Beeinflussung von Entzündungen als potenzieller therapeutischer Ansatz gewidmet, allerdings stellt die Komplexität der Entzündungszellen bezüglich Heterogenität und Funktion eine Herausforderung für die Entwicklung von Strategien zur Immunmodulation dar. Aus diesem Grund ist die Entwicklung von Methoden, mit denen Immunzellen mit hoher Auflösung charakterisiert werden können, für ein besseres Verständnis der Heterogenität und Dynamik von Immunzellen im ischämischen Herzen unerlässlich. In dieser Arbeit haben wir scRNA-seq eingesetzt, um die Heterogenität und Dynamik von Neutrophilen und Monozyten/Makrophagen nach einem experimentell-induzierten Myokardinfarkt zu bestimmen. Neutrophile dringen unmittelbar nach der ischämischen Schädigung in das infarzierte Herz ein wo ihre Zahl innerhalb der ersten Tage abnimmt. Zudem konnten wir eine transkriptionelle Heterogenität in neutrophilen Populationen während der akuten Entzündungsphase beobachten. Insbesondere konnten wir ab dem 3. Tag nach Infarkt einen SiglecFhi-Neutrophilenstatus identifizieren, der sich unseren Daten zufolge im betroffenen Gewebe entwickelt hat. SiglecFhi-Neutrophile zeigten im Vergleich zu neu rekrutierten Neutrophilen eine höhere ROS-Produktion und phagozytische Fähigkeit, was auf den Erwerb einer spezifischen Funktion im infarzierten Herzen hindeutet. Diese Ergebnisse unterstreichen die Wichtigkeit der unmittelbaren Umgebung des Gewebes für die Reaktion der Neutrophilen. Weiterhin zeigten unsere scRNA-seq-Daten eine erhebliche Heterogenität in der Monozyten-/Makrophagenpopulation. Durch die Kombination der scRNA-seq-Analyse von kardialen und zirkulierenden Leukozyten, konnten wir eine durch ischämische Verletzungen induzierte Monozytenpopulation mit einer "neutrophilenähnlichen" Gensignatur identifizieren. Aus der Makrophagenperspektive beobachteten wir verschiedene MI-assoziierte Makrophagenuntergruppen, zwei mit einer pro-inflammatorischen Gensignatur (MHCIIhiIl1βhi) und drei Trem2hi-Makrophagenpopulationen mit einer Lipid-assoziierten Makrophagensignatur (LAM), welche auch pro-fibrotische/Gewebereparaturgene exprimieren. Darüber hinaus entdeckten wir eine kleine Population von Fn1hiLtc4shi-Makrophagen mit unbekannter Funktion, die mit einigen cRTMs-Markern angereichert sind. CCR2-Depletion und Fate-Mapping-Studien zeigten einen eindeutigen monozytären Ursprung der MI-assoziierten Makrophagen-Untergruppen. TREM2 ist ein Oberflächenprotein, das hauptsächlich in Makrophagen exprimiert wird und an der Makrophagenfunktion beteiligt ist. Die Funktion von TREM2 in Makrophagen wird in verschiedenen Krankheitskontexten (z. B. Alzheimer-Krankheit, Fettleibigkeit, Atherosklerose usw.) eingehend untersucht, und ist für den Erwerb der LAM-Signatur wesentlich. In unserem Herzinfarkt-Mausmodell beobachteten wir die Expression von Genen der LAM-Signatur im infarzierten Herzen und dass TREM2 für diese Hochregulation der LAM-Gene in vivo erforderlich ist. Unsere vorläufigen Daten in Trem2-defizienten Mäusen unterstreichen die Rolle von TREM2 zur Förderung eines pro-fibrotischen Makrophagen-Phänotyps und dementsprechend für die pro-fibrotischen/Gewebereparatur-Gensignatur der Trem2-LAM-Signaturgene. Insgesamt liefern unsere Daten eine hochauflösende Charakterisierung der Heterogenität und Dynamik von Neutrophilen und Makrophagen im ischämischen Herzen und können als wertvolle Grundlage für die Untersuchung der Frage dienen, wie diese Zellen die Heilungsprozesse nach einem Herzinfarkt modulieren. KW - Macrophages KW - Neutrophils KW - Myocardial infarction KW - Makrophage KW - Herzinfarkt Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-310680 ER - TY - THES A1 - Frackmann, Kyra T1 - In Vitro Analyse der Glukose- und Methionin-Restriktion im humanen Modellsystem HeLa sowie im Plattenepithelkarzinom HNSCC T1 - In vitro analysis of glucose and methionine restriction in human model system HeLa and head and neck squamous cell carcinoma (HNSCC) N2 - Die Krebserkrankung ist bis zum heutigen Zeitpunkt eine große Belastung in unserer Gesellschaft. Obwohl es stets Fortschritte in der Entwicklung neuer Therapiemöglichkeiten gibt, stellt die Behandlung auch in der modernen Medizin eine enorme Herausforderung dar. Darum besteht bis heute ein hoher Bedarf an neuen und weiterentwickelten Behandlungsmöglichkeiten. Um die Proliferation einer neoplastischen Zelle zu beeinflussen, stellen die Biomasse und die Energie einen grundlegenden Ansatz dar. Hier bieten sich vor allem die Aminosäuren als wesentlicher Baustein der Zellmasse und der Energieträger „Glukose“ an, wodurch sich die beiden Ansätze einer Protein- bzw. Aminosäure-Restriktion und einer Glukose-Restriktion ergeben. Ziel ist es durch eine veränderte Stoffwechsellage einen Low-Energy-Metabolismus (LEM) zu induzieren, welcher die Zelle in einen sich selbst regenerierenden, antiproliferativen Zustand versetzt. Zusätzlich sollte untersucht werden, ob sich die beiden Ansätze grundsätzlich als Therapieform gegen das Plattenepithelkarzinom (HNSCC) eignen. Zudem sollte ein Modell einer humanen Zelllinie erstellt werden, mit Hilfe dessen sich ein LEM auf metaboler Ebene charakterisieren lässt. Die Ergebnisse zeigen, dass Zellen unter konstanter Glukose-Restriktion teils sensitiver auf Todesliganden reagieren. Außerdem wirken Kalorien-Restriktions-Mimetika antiproliferativ auf HNSCC Zellen. Hinzu kommt, dass eine Methionin-Restriktion Einfluss auf die Genexpression jener Gene hat, die mit der LEM-Signalkaskade in Zusammenhang stehen. Zuletzt lieferte die massenspektrometrische Analyse von mehr als 150 Metaboliten der humanen Zelllinie HeLa ein detailliertes Bild ihres Metabolismus unter Methionin-Restriktion. Durch die Definition eines charakteristischen Fingerabdrucks nach 72 h und eines kleinen Fußabdrucks aus wenigen Metaboliten, konnte ein humanes Modellsystem etabliert werden, dass zukünftig u.a. die schnelle Analyse von Kalorien-Restriktions-Mimetika ermöglicht. N2 - Cancer continues to be a major burden in our society to this day. Although there is always progress in the development of new treatment options, treatment remains an enormous challenge even in modern medicine. That is why there is a high demand for new and advanced treatment options to this day. To influence the proliferation of a neoplastic cell, biomass and energy represent a fundamental approach. In this context, amino acids as an essential building block of the cell mass and the energy carrier "glucose" are particularly suitable, resulting in the two approaches of protein or amino acid restriction and glucose restriction. The aim is to induce a low-energy metabolism (LEM) by changing the metabolic state, which will put the cell into a self-regenerating, anti-proliferative state. In addition, it should be investigated whether the two approaches are suitable in principle as a form of therapy against head and neck squamous cell carcinoma (HNSCC). Furthermore, to establish a model of a human cell line that can be used to characterize LEM at the metabolic level. The results show that cells under constant glucose restriction are partly more sensitive to death ligands. Moreover, caloric restriction mimetics have an antiproliferative effect on HNSCC. In addition, methionine restriction has an impact on gene expression of those genes related to the LEM signaling cascade. Most recently, mass spectrometric analysis of more than 150 metabolites from the human cell line HeLa provided a detailed picture of their metabolism under methionine restriction. By defining a characteristic fingerprint after 72 h and a small footprint consisting of a few metabolites, a human model system could be established that will allow, among other things, the rapid analysis of caloric restriction mimetics in the future. KW - Methionin KW - Glucose KW - Plattenepithelcarcinom KW - HeLa-Zelle KW - Massenspektrometrie KW - Methionin-Restriktion KW - Glukose-Restriktion KW - HNSCC Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-311565 ER - TY - THES A1 - Cetindere, Rojan T1 - Klinische und radiologische Ergebnisse nach offener Schultergelenksstabilisierung mittels Beckenkammspan T1 - Clinical and radiological results after repair of shoulder instability due to major glenoid bone loss with open iliac crest bone block reconstruction N2 - Im Rhön-Klinikum wurden von 2012 bis 2015 49 Patient*innen wegen eines Glenoiddefektes mittels offenem Beckenkammspantransfer mit Kapselshift bei anteriorer Schulterinstabilität behandelt. 27 Patienten konnten in dieser Studie eingeschlossen werden (Einschlusskriterien: Follow-up von mindestens 12 Monaten, kompletter präoperativer 3D-CT-Datensatz / Ausschlusskriterien: traumatische Schulterluxation oder Voroperation der kontralateralen Schulter). Ziel der Studie war es, das kurz- bis mittelfristige klinische Outcome dieser Kohorte zu erfassen, der Vergleich mit Ergebnissen anderer Arbeitsgruppen und der Vergleich von präoperativ verwendeten Messmethoden (Chuang- bzw. Wambacher-Methode) für den Glenoiddefekt. Bei einem mittleren Follow-up von 27,11 Monaten zeigten sich überwiegend gute bis exzellente kurz- bis mittelfristige OP-Ergebnisse (Rowe-Score: 84,81, Oxford-Shoulder-Score: 20,56, WOSI-Score: 371, Constant-Score: 86,74). Die OP-Methode eignet sich gut für Patient*innen, die mehrfach voroperiert sind, multiple Luxationsereignisse hatten sowie für diejenigen mit relevanter Hyperlaxizität, bei denen eine Latarjet-Operation kontraindiziert ist. Die OP-Methode ist gut anwendbar bei Patient*innen mit subkritischem Glenoidverlust < 20 %, wenn zusätzliche Sekundärfaktoren vorliegen. Eine postoperative Omarthrose ist ein Risikofaktor für ein signifikant schlechteres Outcome. Die Gesamtkomplikationsrate lag bei 25,9%, der Großteil hiervon (18,3%) waren innerhalb kurzer Zeit reversibel. Die Reluxationsrate lag bei 3,7%. Bei allen Studienteilnehmenden kam es zum Span-Remodelling ohne Schraubenlockerung oder Spanbruch. Eine übermäßige Spanresorbtion erfolgt antero-inferior, während um die Osteosyntheseschrauben eine Überkontur persistiert. Die Glenoiddefekte lagen bei 23,39 % (Chuang) bzw. 22,06 % (Wambacher). Es zeigte sich eine gute Übereinstimmung der Messergebnisse beider Methoden, allerdings lagen die Werte nach Chuang signifikant höher. N2 - From 2012 to 2015, 49 patients with anterior shoulder instability and a glenoid defect were treated at Rhön-Klinikum using an open iliac crest bone graft transfer with capsular shift. 27 patients were included in this study (inclusion criteria: minimum follow-up of 12 months, complete preoperative 3D CT dataset/exclusion criteria: traumatic shoulder dislocation or previous operation of the contralateral shoulder). The aim of the study was to evaluate the short- to medium-term clinical outcomes of this cohort, to compare the results with those of other research groups, and to compare preoperative measurement methods (Chuang and Wambacher methods) for the glenoid defect. At a mean follow-up of 27.11 months, predominantly good to excellent short- to medium-term surgical results were observed (Rowe score: 84.81, Oxford Shoulder Score: 20.56, WOSI Score: 371, Constant score: 86.74). The surgical method is suitable for patients who have had multiple previous operations, multiple dislocation events, and those with significant hyperlaxity in whom Latarjet surgery is contraindicated. The surgical method is also applicable to patients with subcritical glenoid loss of < 20% if additional secondary factors are present. Postoperative osteoarthritis is a risk factor for significantly worse outcomes. The overall complication rate was 25.9%, the majority of which (18.3%) were reversible within a short time. The redislocation rate was 3.7%. All study participants experienced graft remodelling without screw loosening or graft breakage. Excessive graft resorption occurred antero-inferiorly, while an overcontour persisted around the osteosynthesis screws. The glenoid defects were 23.39% (Chuang) and 22.06% (Wambacher). There was good agreement between the measurement results of both methods, although the values according to the Chuang method were significantly higher. KW - Orthopädie KW - Beckenkammtransfer KW - Kapselshift KW - iliac crest transfer KW - Schulterinstabilität Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-313148 ER - TY - THES A1 - Klinnert Vlachopoulou, Cristina Maria T1 - Comparison between Dual-Energy-CT perfusion imaging and perfusion-weighted SElf-gated Non-Contrast-Enhanced FUnctional MR imaging of the lung in patients with pulmonary artery embolism T1 - Vergleich zwischen Perfusionskarten der Lunge des DECT und "SElf-gated Non-Contrast-Enhanced Functional” MRT bei Patienten mit einer Lungenembolie N2 - Pulmonary artery embolism (PE) is a common condition and an even more common clinical suspect. The computed tomography pulmonary angiogram (CTPA) is the main medical imaging tool used to diagnose a suspected case of PE. To gain a better impression of the effects of a PE on the perfusion and hence the gas exchange, a functional imaging method is beneficial. One approach for functional imaging using radiation exposure is the generation of color-coded iodine perfusion maps acquired by Dual-Energy Computed Tomography (DECT), which enable the detection of perfusion defects in the pulmonary parenchyma. In contrast to the existing approach of DECT with iodine color-coded maps, the SElf-gated Non-Contrast-Enhanced FUnctional Lung (SENCEFUL) MRI technique offers the possibility to interpret perfusion maps without any radiation exposure or application of contrast agents. The measurement in SENCEFUL MRI can be performed during conditions of free breathing and without electrocardiogram triggering. The purpose of this study was to determine whether PE can be diagnosed on the basis of visible perfusion defects in the perfusion maps of SENCEFUL MRI and in the iodine-coded maps of DECT and to compare the diagnostic performance of these methods. Both SENCEFUL-MRI and iodine distribution maps from DECT have been compared with the CTPA of ten patients with PE. Additionally, the functional images were compared with each other on a per-patient basis. The iodine perfusion maps of DECT had a sensitivity of 84.2 % and specificity of 65.2 % for the diagnosis of PE. The SENCEFUL technique in MRI showed a sensitivity of 78.9 % and a specificity of 26.1 %. When comparing the whole lung depicted in both series of functional images, the main perfusion defect location matched in four of ten patients (40 %). In conclusion, this work found that DECT iodine maps have higher sensitivity and specificity in the diagnosis of pulmonary embolism compared with SENCEFUL MRI. N2 - Die Lungenembolie (LE) ist eine häufige Erkrankung und eine noch häufigere Verdachtsdiagnose. Die Computertomographie der Pulmonalarterien (CTPA) ist die Bildgebung erster Wahl für die Diagnose einer LE. Für eine bessere Darstellung der Folgen einer LE dienen Perfusionskarten. Eine existierende Bildgebungstechnik mit ionisierender Strahlung sind die Iodkarten der Dual-Energy-Computertomographie (DECT), welche bei einer LE Perfusionsdefekte im Lungenparenchym wiedergeben. Eine weitere strahlungsfreie und kontrastmittelfreie Methode ist die „SElf-gated Non-Contrast-Enhanced FUnctional Lung” (SENCEFUL) Magnet-Resonanz-Tomographie (MRT). Diese Technik kann ohne Atemhaltemanöver und ohne EKG-Monitoring stattfinden. Ziel der Arbeit war es zu bestimmen, ob eine LE aufgrund eines Perfusionsdefekts in den Iodkarten des DECT und SENCEFUL MRT diagnostiziert werden kann. Beide Bildgebungstechniken wurden mit der CTPA von zehn Patienten mit LE verglichen. Außerdem wurden die Perfusionsbilder untereinander verglichen. Die Iodkarten hatten eine Sensitivität von 84.2 % und eine Spezifizität von 65.2 %. Die SENCEFUL MRT Bilder zeigten eine Sensitivität von 78.9 % und eine Spezifizität von 26.1 %. Der Vergleich beider funktioneller Bildgebungstechniken bezogen auf die gesamte Lunge ergab, dass in vier von zehn Patienten die prädominierende Lokalisation der Minderperfusion übereinstimmte. Zusammenfassend konnte in dieser Arbeit festgestellt werden, dass die Iodkarten des DECTs im Vergleich zum SENCEFUL MRT eine höhere Sensitivität und Spezifizität in der Diagnose einer Lungenembolie aufweisen. KW - Lungenembolie KW - pulmonary embolism KW - perfusion map Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-313034 ER - TY - JOUR A1 - Schwaab, Bernhard A1 - Bjarnason-Wehrens, Birna A1 - Meng, Karin A1 - Albus, Christian A1 - Salzwedel, Annett A1 - Schmid, Jean-Paul A1 - Benzer, Werner A1 - Metz, Matthes A1 - Jensen, Katrin A1 - Rauch, Bernhard A1 - Bönner, Gerd A1 - Brzoska, Patrick A1 - Buhr-Schinner, Heike A1 - Charrier, Albrecht A1 - Cordes, Carsten A1 - Dörr, Gesine A1 - Eichler, Sarah A1 - Exner, Anne-Kathrin A1 - Fromm, Bernd A1 - Gielen, Stephan A1 - Glatz, Johannes A1 - Gohlke, Helmut A1 - Grilli, Maurizio A1 - Gysan, Detlef A1 - Härtel, Ursula A1 - Hahmann, Harry A1 - Herrmann-Lingen, Christoph A1 - Karger, Gabriele A1 - Karoff, Marthin A1 - Kiwus, Ulrich A1 - Knoglinger, Ernst A1 - Krusch, Christian-Wolfgang A1 - Langheim, Eike A1 - Mann, Johannes A1 - Max, Regina A1 - Metzendorf, Maria-Inti A1 - Nebel, Roland A1 - Niebauer, Josef A1 - Predel, Hans-Georg A1 - Preßler, Axel A1 - Razum, Oliver A1 - Reiss, Nils A1 - Saure, Daniel A1 - von Schacky, Clemens A1 - Schütt, Morten A1 - Schultz, Konrad A1 - Skoda, Eva-Maria A1 - Steube, Diethard A1 - Streibelt, Marco A1 - Stüttgen, Martin A1 - Stüttgen, Michaela A1 - Teufel, Martin A1 - Tschanz, Hansueli A1 - Völler, Heinz A1 - Vogel, Heiner A1 - Westphal, Ronja T1 - Cardiac rehabilitation in German speaking countries of Europe — evidence-based guidelines from Germany, Austria and Switzerland LLKardReha-DACH — part 2 JF - Journal of Clinical Medicine N2 - Background: Scientific guidelines have been developed to update and harmonize exercise based cardiac rehabilitation (ebCR) in German speaking countries. Key recommendations for ebCR indications have recently been published in part 1 of this journal. The present part 2 updates the evidence with respect to contents and delivery of ebCR in clinical practice, focusing on exercise training (ET), psychological interventions (PI), patient education (PE). In addition, special patients' groups and new developments, such as telemedical (Tele) or home-based ebCR, are discussed as well. Methods: Generation of evidence and search of literature have been described in part 1. Results: Well documented evidence confirms the prognostic significance of ET in patients with coronary artery disease. Positive clinical effects of ET are described in patients with congestive heart failure, heart valve surgery or intervention, adults with congenital heart disease, and peripheral arterial disease. Specific recommendations for risk stratification and adequate exercise prescription for continuous-, interval-, and strength training are given in detail. PI when added to ebCR did not show significant positive effects in general. There was a positive trend towards reduction in depressive symptoms for “distress management” and “lifestyle changes”. PE is able to increase patients’ knowledge and motivation, as well as behavior changes, regarding physical activity, dietary habits, and smoking cessation. The evidence for distinct ebCR programs in special patients’ groups is less clear. Studies on Tele-CR predominantly included low-risk patients. Hence, it is questionable, whether clinical results derived from studies in conventional ebCR may be transferred to Tele-CR. Conclusions: ET is the cornerstone of ebCR. Additional PI should be included, adjusted to the needs of the individual patient. PE is able to promote patients self-management, empowerment, and motivation. Diversity-sensitive structures should be established to interact with the needs of special patient groups and gender issues. Tele-CR should be further investigated as a valuable tool to implement ebCR more widely and effectively. KW - cardiac rehabilitation KW - scientific guidelines KW - secondary prevention KW - physical activity KW - exercise training KW - psychological interventions KW - education KW - gender KW - frailty KW - migration KW - old patients KW - young patients KW - tele-medicine KW - home-based-rehabilitation Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-242645 SN - 2077-0383 VL - 10 IS - 14 ER - TY - JOUR A1 - Chilaka, Cynthia Adaku A1 - Obidiegwu, Jude Ejikeme A1 - Chilaka, Augusta Chinenye A1 - Atanda, Olusegun Oladimeji A1 - Mally, Angela T1 - Mycotoxin regulatory status in Africa: a decade of weak institutional efforts JF - Toxins N2 - Food safety problems are a major hindrance to achieving food security, trade, and healthy living in Africa. Fungi and their secondary metabolites, known as mycotoxins, represent an important concern in this regard. Attempts such as agricultural, storage, and processing practices, and creation of awareness to tackle the menace of fungi and mycotoxins have yielded measurable outcomes especially in developed countries, where there are comprehensive mycotoxin legislations and enforcement schemes. Conversely, most African countries do not have mycotoxin regulatory limits and even when available, are only applied for international trade. Factors such as food insecurity, public ignorance, climate change, poor infrastructure, poor research funding, incorrect prioritization of resources, and nonchalant attitudes that exist among governmental organisations and other stakeholders further complicate the situation. In the present review, we discuss the status of mycotoxin regulation in Africa, with emphasis on the impact of weak mycotoxin legislations and enforcement on African trade, agriculture, and health. Furthermore, we discuss the factors limiting the establishment and control of mycotoxins in the region. KW - fungi KW - mycotoxin KW - legislation KW - food safety KW - food security Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-278941 SN - 2072-6651 VL - 14 IS - 7 ER - TY - JOUR A1 - Winkelbeiner, Nicola A1 - Wandt, Viktoria K. A1 - Ebert, Franziska A1 - Lossow, Kristina A1 - Bankoglu, Ezgi E. A1 - Martin, Maximilian A1 - Mangerich, Aswin A1 - Stopper, Helga A1 - Bornhorst, Julia A1 - Kipp, Anna P. A1 - Schwerdtle, Tanja T1 - A multi-endpoint approach to base excision repair incision activity augmented by PARylation and DNA damage levels in mice: impact of sex and age JF - International Journal of Molecular Sciences N2 - Investigation of processes that contribute to the maintenance of genomic stability is one crucial factor in the attempt to understand mechanisms that facilitate ageing. The DNA damage response (DDR) and DNA repair mechanisms are crucial to safeguard the integrity of DNA and to prevent accumulation of persistent DNA damage. Among them, base excision repair (BER) plays a decisive role. BER is the major repair pathway for small oxidative base modifications and apurinic/apyrimidinic (AP) sites. We established a highly sensitive non-radioactive assay to measure BER incision activity in murine liver samples. Incision activity can be assessed towards the three DNA lesions 8-oxo-2'-deoxyguanosine (8-oxodG), 5-hydroxy-2'-deoxyuracil (5-OHdU), and an AP site analogue. We applied the established assay to murine livers of adult and old mice of both sexes. Furthermore, poly(ADP-ribosyl)ation (PARylation) was assessed, which is an important determinant in DDR and BER. Additionally, DNA damage levels were measured to examine the overall damage levels. No impact of ageing on the investigated endpoints in liver tissue were found. However, animal sex seems to be a significant impact factor, as evident by sex-dependent alterations in all endpoints investigated. Moreover, our results revealed interrelationships between the investigated endpoints indicative for the synergetic mode of action of the cellular DNA integrity maintaining machinery. KW - maintenance of genomic integrity KW - ageing KW - sex KW - DNA damage KW - base excision repair (incision activity) KW - DNA damage response KW - poly(ADP-ribosyl)ation KW - liver Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-285706 SN - 1422-0067 VL - 21 IS - 18 ER - TY - JOUR A1 - Tolstik, Elen A1 - Ali, Nairveen A1 - Guo, Shuxia A1 - Ebersbach, Paul A1 - Möllmann, Dorothe A1 - Arias-Loza, Paula A1 - Dierks, Johann A1 - Schuler, Irina A1 - Freier, Erik A1 - Debus, Jörg A1 - Baba, Hideo A. A1 - Nordbeck, Peter A1 - Bocklitz, Thomas A1 - Lorenz, Kristina T1 - CARS imaging advances early diagnosis of cardiac manifestation of Fabry disease JF - International Journal of Molecular Sciences N2 - Vibrational spectroscopy can detect characteristic biomolecular signatures and thus has the potential to support diagnostics. Fabry disease (FD) is a lipid disorder disease that leads to accumulations of globotriaosylceramide in different organs, including the heart, which is particularly critical for the patient’s prognosis. Effective treatment options are available if initiated at early disease stages, but many patients are late- or under-diagnosed. Since Coherent anti-Stokes Raman (CARS) imaging has a high sensitivity for lipid/protein shifts, we applied CARS as a diagnostic tool to assess cardiac FD manifestation in an FD mouse model. CARS measurements combined with multivariate data analysis, including image preprocessing followed by image clustering and data-driven modeling, allowed for differentiation between FD and control groups. Indeed, CARS identified shifts of lipid/protein content between the two groups in cardiac tissue visually and by subsequent automated bioinformatic discrimination with a mean sensitivity of 90–96%. Of note, this genotype differentiation was successful at a very early time point during disease development when only kidneys are visibly affected by globotriaosylceramide depositions. Altogether, the sensitivity of CARS combined with multivariate analysis allows reliable diagnostic support of early FD organ manifestation and may thus improve diagnosis, prognosis, and possibly therapeutic monitoring of FD. KW - coherent anti-Stokes Raman scattering (CARS) microscopy KW - Raman micro-spectroscopy KW - cardiovascular diseases KW - Fabry Disease (FD) KW - Gb3 and lyso-Gb3 biomarkers KW - multivariate data analysis KW - immunohistochemistry Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-284427 SN - 1422-0067 VL - 23 IS - 10 ER - TY - THES A1 - Klabouch [geb. Kleinbach], Stefanie T1 - Prädiktoren für die postinterventionelle Leberfunktion nach transarterieller Chemotherapie bei Patienten und Patientinnen mit hepatozellulärem Karzinom T1 - Predictors of postinterventional liver function after transarterial chemoembolization in patients with hepatocellular carcinoma N2 - Hintergrund: Die transarterielle Chemoembolisation (TACE) stellt eine Erstlinientherapie bei nicht resezierbarem HCC im intermediären Stadium (BCLC B) dar. TACE induziert einen zytotoxischen und ischämischen Gewebeeffekt, der möglicherweise zu einer Leberfunktionsstörung führt. Der 13C-Methacetin-Atemtest (MBT) ist ein nichtinvasiver CYP1A2-Funktionstest zur Beurteilung der funktionellen Leberzellmasse. Ziel dieser prospektiven Studie war es, die Auswirkung der konventionellen TACE auf die hepatozelluläre Reserve, gemessen mittels 13C-MBT, statischen Leberfunktionstests und entzündlichen Parametern bewerten zu können. Methoden & Ergebnisse: 27 Patient*innen mit nicht resezierbarem HCC (BCLC B, Child Pugh A) erhielten vor (d0), 24 Stunden (d1) und 72 Stunden (d3) nach 41 cTACE-Verfahren einen MBT. Das hepatische Lipiodol®-Verteilungsvolumen wurde aus CT-Daten berechnet. Statische Leberfunktionstests, entzündliche Parameter und klinische Ereignisse wurden an d0-3 analysiert. Es zeigte sich eine deutliche Verringerung der CYP1A2-Funktion nach cTACE an d1 und d3, was hauptsächlich durch die Entzündungsreaktion (CRP) und hepatozelluläre Schadensmarker (AST) und nur in geringem Maße durch das embolisierte Lebervolumen zu erklären ist. Schlussfolgerung: Der MBT kann die kurzfristige Verringerung der Leberfunktionsreserve sensitiv abbilden und korreliert mit klinischen Komplikationen nach cTACE. Der MBT kann Anwendung in der frühen Identifizierung einer hepatischen Dysfunktion finden. N2 - Background: Transarterial Chemoembolization (TACE) is a standard therapy for unresectable HCC and is suggested as first line-therapy for intermediate stages (BCLC B). TACE induces a cytotoxic and ischemic tissue effect potentially leading to hepatic dysfunction. 13C-methacetin breath test (MBT) is a noninvasive CYP1A2 function test for the assessment of hepatic functional reserve. We aimed to assess by MBT the effect of conventional TACE on hepatic functional reserve, static functional and inflammatory parameters. Methods & Results: 27 patients with unresectable HCC (BCLC B, Child Pugh A) underwent MBT before (d0), 24h (d1) and 72h (d3) after 41 cTACE procedures. Hepatic Lipiodol® distribution volumes were calculated from CT data. Static liver function, inflammatory markers and clinical events were assessed at d0-3. A rapid and marked reduction of CYP1A2 function occurred on d1 and d3, mainly explained by the inflammatory response (CRP) and hepatocellular damage markers (AST) but to a minor extent by hepatic embolization volumes. Conclusion: MBT can sensitively monitor short-term reduction in hepatic functional reserve and correlates with clinical complications after cTACE. MBT might be useful in the early identification of patients with hepatic dysfunction. KW - Leberfunktion KW - Leberzellkrebs KW - Kohlenstoff-13-Exhalationstest KW - Leberzirrhose KW - Leberversagen KW - Transarterielle Chemoembolisation KW - 13C-Methacetin-Atemtest KW - Hepatozelluläres Karzinom KW - Mikrosomale Leberfunktion Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-237070 ER -